<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">J Int Soc Sports Nutr</journal-id><journal-id journal-id-type="iso-abbrev">J Int Soc Sports Nutr</journal-id><journal-title-group><journal-title>Journal of the International Society of Sports Nutrition</journal-title></journal-title-group><issn pub-type="epub">1550-2783</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29410606</article-id><article-id pub-id-type="pmc">5781260</article-id><article-id pub-id-type="publisher-id">208</article-id><article-id pub-id-type="doi">10.1186/s12970-018-0208-0</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Effects of lemon verbena extract (Recoverben®) supplementation on muscle strength and recovery after exhaustive exercise: a randomized, placebo-controlled trial</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0462-6620</contrib-id><name><surname>Buchwald-Werner</surname><given-names>Sybille</given-names></name><address><email>sybille.buchwald-werner@vitalsolutions.biz</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Naka</surname><given-names>Ioanna</given-names></name><address><email>ioanna.naka@vitalsolutions.biz</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Wilhelm</surname><given-names>Manfred</given-names></name><address><email>wilhelm@hs-ulm.de</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Schütz</surname><given-names>Elivra</given-names></name><address><email>e.thomas@biotesys.de</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Schoen</surname><given-names>Christiane</given-names></name><address><email>c.schoen@biotesys.de</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Reule</surname><given-names>Claudia</given-names></name><address><email>c.reule@biotesys.de</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label>Vital Solutions GmbH, Hausingerstrasse 6, 40764 Langenfeld, Germany </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0212 3272</institution-id><institution-id institution-id-type="GRID">grid.434100.2</institution-id><institution>Ulm University of Applied Sciences, </institution></institution-wrap>Albert-Einstein-Allee 55, 89081 Ulm, Germany </aff><aff id="Aff3"><label>3</label>BioTeSys GmbH, Schelztorstrasse 54-56, D-73728 Esslingen, Germany </aff></contrib-group><pub-date pub-type="epub"><day>23</day><month>1</month><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>23</day><month>1</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>15</volume><elocation-id>5</elocation-id><history><date date-type="received"><day>1</day><month>9</month><year>2017</year></date><date date-type="accepted"><day>5</day><month>1</month><year>2018</year></date></history><permissions><copyright-statement>© The Author(s). 2018</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title><offsets xml_i="4572" xml_f="4582" txt_i="11" txt_f="21">Background</offsets></title><p><offsets xml_i="4593" xml_f="5056" txt_i="22" txt_f="485">Exhaustive exercise causes muscle damage accompanied by oxidative stress and inflammation leading to muscle fatigue and muscle soreness. Lemon verbena leaves, commonly used as tea and refreshing beverage, demonstrated antioxidant and anti-inflammatory properties. The aim of this study was to investigate the effects of a proprietary lemon verbena extract (Recoverben®) on muscle strength and recovery after exhaustive exercise in comparison to a placebo product.</offsets></p></sec><sec><title><offsets xml_i="5078" xml_f="5085" txt_i="487" txt_f="494">Methods</offsets></title><p><offsets xml_i="5096" xml_f="5702" txt_i="495" txt_f="1101">The study was performed as a randomized, placebo-controlled, double-blind study with parallel design. Forty-four healthy males and females, which were 22–50 years old and active in sports, were randomized to 400 mg lemon verbena extract once daily or placebo. The 15 days intervention was divided into 10 days supplementation prior to the exhaustive exercise day (intensive jump-protocol), one day during the test and four days after. Muscle strength (MVC), muscle damage (CK), oxidative stress (GPx), inflammation (IL6) and volunteer-reported muscle soreness intensity were assessed pre and post exercise.</offsets></p></sec><sec><title><offsets xml_i="5724" xml_f="5731" txt_i="1103" txt_f="1110">Results</offsets></title><p><offsets xml_i="5742" xml_f="5984" txt_i="1111" txt_f="1353">Participants in the lemon verbena group benefited from less muscle damage as well as faster and full recovery. Compared to placebo, lemon verbena extract receiving participants had significantly less exercise-related loss of muscle strength (</offsets><italic><offsets xml_i="5992" xml_f="5993" txt_i="1353" txt_f="1354">p</offsets></italic><offsets xml_i="6002" xml_f="6085" txt_i="1354" txt_f="1437"> = 0.0311) over all timepoints, improved glutathione peroxidase activity by trend (</offsets><italic><offsets xml_i="6093" xml_f="6094" txt_i="1437" txt_f="1438">p</offsets></italic><offsets xml_i="6103" xml_f="6146" txt_i="1438" txt_f="1481"> = 0.0681) and less movement induced pain (</offsets><italic><offsets xml_i="6154" xml_f="6155" txt_i="1481" txt_f="1482">p</offsets></italic><offsets xml_i="6164" xml_f="6265" txt_i="1482" txt_f="1583"> = 0.0788) by trend. Creatine kinase and IL-6 didn’t show significant discrimmination between groups.</offsets></p></sec><sec><title><offsets xml_i="6287" xml_f="6297" txt_i="1585" txt_f="1595">Conclusion</offsets></title><p><offsets xml_i="6308" xml_f="6470" txt_i="1596" txt_f="1758">Lemon verbena extract (Recoverben®) has been shown to be a safe and well-tolerated natural sports ingredient, by reducing muscle damage after exhaustive exercise.</offsets></p></sec><sec><title><offsets xml_i="6492" xml_f="6510" txt_i="1760" txt_f="1778">Trial registration</offsets></title><p><offsets xml_i="6521" xml_f="6598" txt_i="1779" txt_f="1856">The trial was registered in the clinical trials registry (clinical trial.gov </offsets><ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT02923102"><offsets xml_i="6689" xml_f="6700" txt_i="1856" txt_f="1867">NCT02923102</offsets></ext-link><offsets xml_i="6711" xml_f="6742" txt_i="1867" txt_f="1898">). Registered 28 September 2016</offsets></p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Sports nutrition</kwd><kwd>Lemon verbena</kwd><kwd><italic>Aloysia citriodora</italic></kwd><kwd>Recoverben®</kwd><kwd>Muscle strength</kwd><kwd>Recovery</kwd><kwd>Exhaustive exercise</kwd><kwd>eiMD</kwd><kwd>Muscle soreness</kwd><kwd>Glutathione peroxidases</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>© The Author(s) 2018</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title><offsets xml_i="7302" xml_f="7312" txt_i="1907" txt_f="1917">Background</offsets></title><p id="Par11"><offsets xml_i="7334" xml_f="7499" txt_i="1918" txt_f="2083">All kinds of training, moderate, exhaustive or unaccustomed, cause so-called exercise-induced muscle damage (eiMD) accompanied by oxidative stress and inflammation [</offsets><xref ref-type="bibr" rid="CR1"><offsets xml_i="7531" xml_f="7532" txt_i="2083" txt_f="2084">1</offsets></xref><offsets xml_i="7539" xml_f="7769" txt_i="2084" txt_f="2314">]. Delayed onset muscle soreness (DOMS) is the most common symptom of eiMD, whereas histological evidence of disruption of the myofibrillar structure and myofibre necrosis, as well as inflammation, are the ultimate signs of eiMD [</offsets><xref ref-type="bibr" rid="CR1"><offsets xml_i="7801" xml_f="7802" txt_i="2314" txt_f="2315">1</offsets></xref><offsets xml_i="7809" xml_f="8068" txt_i="2315" txt_f="2574">]. DOMS is associated with muscle fatigue and muscle soreness, symptoms, which last for a number of days and have a negative impact on the exercise performance of athletes and amateur sports people, especially when they carry out long-term training programs [</offsets><xref ref-type="bibr" rid="CR1"><offsets xml_i="8100" xml_f="8101" txt_i="2574" txt_f="2575">1</offsets></xref><offsets xml_i="8108" xml_f="8405" txt_i="2575" txt_f="2872">]. Incomplete regeneration of myofibrillar structures and metabolic processes before the next training increases the risk for secondary injuries. Therefore, it is important for the adherence to training plans and for the training success that regeneration is as effective and as short as possible.</offsets></p><p id="Par12"><offsets xml_i="8423" xml_f="8743" txt_i="2873" txt_f="3193">A product that could accelerate recovery from DOMS or muscular fatigue would be beneficial not only for high performance athletes, but also for amateur athletes, enabling them to train more frequently or reduce the risk of injury. As inflammation and ROS (reactive oxygen species) are presumably the main cause of DOMS [</offsets><xref ref-type="bibr" rid="CR1"><offsets xml_i="8775" xml_f="8776" txt_i="3193" txt_f="3194">1</offsets></xref><offsets xml_i="8783" xml_f="8977" txt_i="3194" txt_f="3388">], it is hypothesized that natural ingredients with anti-inflammatory and antioxidative properties may help in accelerating or supporting the regeneration after muscle damage inducing exercise [</offsets><xref ref-type="bibr" rid="CR2"><offsets xml_i="9009" xml_f="9010" txt_i="3388" txt_f="3389">2</offsets></xref><offsets xml_i="9017" xml_f="9018" txt_i="3389" txt_f="3390">–</offsets><xref ref-type="bibr" rid="CR4"><offsets xml_i="9050" xml_f="9051" txt_i="3390" txt_f="3391">4</offsets></xref><offsets xml_i="9058" xml_f="9281" txt_i="3391" txt_f="3614">]. The use of supplements with antioxidative or anti-inflammatory effects in the sports nutrition is already widespread. Many of these ingredients and products have been investigated in recent years; for example, curcumin [</offsets><xref ref-type="bibr" rid="CR5"><offsets xml_i="9313" xml_f="9314" txt_i="3614" txt_f="3615">5</offsets></xref><offsets xml_i="9321" xml_f="9345" txt_i="3615" txt_f="3639">], omega-3 fatty acids [</offsets><xref ref-type="bibr" rid="CR6"><offsets xml_i="9377" xml_f="9378" txt_i="3639" txt_f="3640">6</offsets></xref><offsets xml_i="9385" xml_f="9387" txt_i="3640" txt_f="3642">, </offsets><xref ref-type="bibr" rid="CR7"><offsets xml_i="9419" xml_f="9420" txt_i="3642" txt_f="3643">7</offsets></xref><offsets xml_i="9427" xml_f="9446" txt_i="3643" txt_f="3662">] and polyphenols [</offsets><xref ref-type="bibr" rid="CR2"><offsets xml_i="9478" xml_f="9479" txt_i="3662" txt_f="3663">2</offsets></xref><offsets xml_i="9486" xml_f="9488" txt_i="3663" txt_f="3665">, </offsets><xref ref-type="bibr" rid="CR8"><offsets xml_i="9520" xml_f="9521" txt_i="3665" txt_f="3666">8</offsets></xref><offsets xml_i="9528" xml_f="9529" txt_i="3666" txt_f="3667">–</offsets><xref ref-type="bibr" rid="CR10"><offsets xml_i="9562" xml_f="9564" txt_i="3667" txt_f="3669">10</offsets></xref><offsets xml_i="9571" xml_f="9573" txt_i="3669" txt_f="3671">].</offsets></p><p id="Par13"><offsets xml_i="9591" xml_f="9606" txt_i="3672" txt_f="3687">Lemon verbena (</offsets><italic><offsets xml_i="9614" xml_f="9637" txt_i="3687" txt_f="3710">Aloysia citriodora (L.)</offsets></italic><offsets xml_i="9646" xml_f="9853" txt_i="3710" txt_f="3917">) is an annual eatable herbaceous plant native to South America commonly used as tea, refreshing beverage, food, or spice. Traditional medicinal applications are related to digestion and nervous discomfort [</offsets><xref ref-type="bibr" rid="CR11"><offsets xml_i="9886" xml_f="9888" txt_i="3917" txt_f="3919">11</offsets></xref><offsets xml_i="9895" xml_f="10258" txt_i="3919" txt_f="4282">]. A literature search focusing on peer-reviewed publications showed that only limited data are available for lemon verbena in connection with muscular recovery after exercise. PubMed listed over 80 publications in June 2017, that investigated lemon verbena as stand-alone product or in combination with other ingredients in any context (keywords for search were </offsets><italic><offsets xml_i="10266" xml_f="10284" txt_i="4282" txt_f="4300">Aloysia citriodora</offsets></italic><offsets xml_i="10293" xml_f="10295" txt_i="4300" txt_f="4302">, </offsets><italic><offsets xml_i="10303" xml_f="10320" txt_i="4302" txt_f="4319">Lippia citriodora</offsets></italic><offsets xml_i="10329" xml_f="10331" txt_i="4319" txt_f="4321">, </offsets><italic><offsets xml_i="10339" xml_f="10355" txt_i="4321" txt_f="4337">Lippia triphylla</offsets></italic><offsets xml_i="10364" xml_f="10366" txt_i="4337" txt_f="4339">, </offsets><italic><offsets xml_i="10374" xml_f="10392" txt_i="4339" txt_f="4357">Aloysia triphylla,</offsets></italic><offsets xml_i="10401" xml_f="10421" txt_i="4357" txt_f="4377"> and lemon verbena).</offsets></p><p id="Par14"><offsets xml_i="10439" xml_f="10552" txt_i="4378" txt_f="4491">Analytical references demonstrate that water-based extracts out of lemon verbena leaves are high in polyphenols [</offsets><xref ref-type="bibr" rid="CR12"><offsets xml_i="10585" xml_f="10587" txt_i="4491" txt_f="4493">12</offsets></xref><offsets xml_i="10594" xml_f="10596" txt_i="4493" txt_f="4495">, </offsets><xref ref-type="bibr" rid="CR13"><offsets xml_i="10629" xml_f="10631" txt_i="4495" txt_f="4497">13</offsets></xref><offsets xml_i="10638" xml_f="10734" txt_i="4497" txt_f="4593">]. Several in vitro and in vivo studies have shown antioxidative and anti-inflammatory effects [</offsets><xref ref-type="bibr" rid="CR11"><offsets xml_i="10767" xml_f="10769" txt_i="4593" txt_f="4595">11</offsets></xref><offsets xml_i="10776" xml_f="10778" txt_i="4595" txt_f="4597">, </offsets><xref ref-type="bibr" rid="CR14"><offsets xml_i="10811" xml_f="10813" txt_i="4597" txt_f="4599">14</offsets></xref><offsets xml_i="10820" xml_f="10821" txt_i="4599" txt_f="4600">–</offsets><xref ref-type="bibr" rid="CR18"><offsets xml_i="10854" xml_f="10856" txt_i="4600" txt_f="4602">18</offsets></xref><offsets xml_i="10863" xml_f="10892" txt_i="4602" txt_f="4631">]. Out of six human studies [</offsets><xref ref-type="bibr" rid="CR19"><offsets xml_i="10925" xml_f="10927" txt_i="4631" txt_f="4633">19</offsets></xref><offsets xml_i="10934" xml_f="10935" txt_i="4633" txt_f="4634">–</offsets><xref ref-type="bibr" rid="CR24"><offsets xml_i="10968" xml_f="10970" txt_i="4634" txt_f="4636">24</offsets></xref><offsets xml_i="10977" xml_f="11156" txt_i="4636" txt_f="4815">], only one human pilot study was published investigating lemon verbena extract on the muscular damage biomarker, creatine kinase and liver biomarker related to oxidative stress [</offsets><xref ref-type="bibr" rid="CR19"><offsets xml_i="11189" xml_f="11191" txt_i="4815" txt_f="4817">19</offsets></xref><offsets xml_i="11198" xml_f="11695" txt_i="4817" txt_f="5314">]. This study showed some effects on cytokines and oxidative stress markers in neutrophils, but no functional parameters like muscle strength or muscle soreness were essessed. Furthermore, this study used a high dosage of 1800 mg/day which is not suitable for application in food supplements as it would require the intake of approximatley nine capsules per day. Therefore, further research to observe effects of lemon verbena on muscle damage, muscle soreness, and recovery needs to be performed.</offsets></p><p id="Par15"><offsets xml_i="11713" xml_f="11854" txt_i="5315" txt_f="5456">A proprietary lemon verbena extract (Recoverben®), high in polyphenols, was developed and recently identified as an anti-inflammatory agent [</offsets><xref ref-type="bibr" rid="CR25"><offsets xml_i="11887" xml_f="11889" txt_i="5456" txt_f="5458">25</offsets></xref><offsets xml_i="11896" xml_f="12010" txt_i="5458" txt_f="5572">]. One mode of action responsible for the anti-inflammatory properties is the inhibition of cyclooxygenase (COX) [</offsets><xref ref-type="bibr" rid="CR26"><offsets xml_i="12043" xml_f="12045" txt_i="5572" txt_f="5574">26</offsets></xref><offsets xml_i="12052" xml_f="12116" txt_i="5574" txt_f="5638">]. COX inhibition properties have also been shown for curcumin [</offsets><xref ref-type="bibr" rid="CR27"><offsets xml_i="12149" xml_f="12151" txt_i="5638" txt_f="5640">27</offsets></xref><offsets xml_i="12158" xml_f="12233" txt_i="5640" txt_f="5715">], which is also an natural ingredient shown to be beneficial in recovery [</offsets><xref ref-type="bibr" rid="CR5"><offsets xml_i="12265" xml_f="12266" txt_i="5715" txt_f="5716">5</offsets></xref><offsets xml_i="12273" xml_f="12275" txt_i="5716" txt_f="5718">, </offsets><xref ref-type="bibr" rid="CR28"><offsets xml_i="12308" xml_f="12310" txt_i="5718" txt_f="5720">28</offsets></xref><offsets xml_i="12317" xml_f="12761" txt_i="5720" txt_f="6164">]. Based on these data and on data from literature, we hypothesized that a lemon verbena extract (Recoverben®) could have beneficial effects on exercise induced muscle damage, muscle soreness, and recovery. The aim of this study was to investigate effects on functional, metabolic, and subjective parameters of recovery. Furthermore, parameters indicating antioxidative and anti-inflammatory properties were included to document mode of action.</offsets></p></sec><sec id="Sec2"><title><offsets xml_i="12793" xml_f="12800" txt_i="6166" txt_f="6173">Methods</offsets></title><sec id="Sec3"><title><offsets xml_i="12830" xml_f="12842" txt_i="6174" txt_f="6186">Study design</offsets></title><p id="Par16"><offsets xml_i="12864" xml_f="13603" txt_i="6187" txt_f="6926">This study was a double blind, randomized controlled trial with a parallel-group design that investigated the effects of a proprietary lemon verbena extract (Recoverben®) supplementation on muscle strength and recovery after exhausive exercise. It was conducted in orientation to the ICH-GCP guidelines, in compliance with the declaration of Helsinki, and was reviewed by the Institutional Review Board (IRB) “Landesärztekammer Baden Württemberg” without concerns (F-2016-080 September 13th, 2016). All subjects signed the IRB-approved informed consent prior to any procedures. The study was performed from October 2016 to March 2017 at BioTeSys GmbH, Esslingen, Germany, an independent study site which is focused on nutritional research.</offsets></p></sec><sec id="Sec4"><title><offsets xml_i="13635" xml_f="13643" txt_i="6928" txt_f="6936">Subjects</offsets></title><p id="Par17"><offsets xml_i="13665" xml_f="14136" txt_i="6937" txt_f="7408">Subjects were recruited from internal database of the study site, advertisements in local newspapers, and notice boards in public buildings. Seventy subjects responded to the advertising campaign and received detailed information about the study. Out of these, 45 subjects were invited for screening visits. Forty-four healthy, non-smoking, moderately active (exercise 1–3 times per week) men and women with an age between 22 and 50 years and a BMI between 19 and 30 kg/m</offsets><sup><offsets xml_i="14141" xml_f="14142" txt_i="7408" txt_f="7409">2</offsets></sup><offsets xml_i="14148" xml_f="14347" txt_i="7409" txt_f="7608"> were deemed eligible for the current study. Subjects had a usual intake of five or less portions of fruits plus vegetables per day. Detailed inclusion- and exclusion criteria are presented in Table </offsets><xref rid="Tab1" ref-type="table"><offsets xml_i="14381" xml_f="14382" txt_i="7608" txt_f="7609">1</offsets></xref><offsets xml_i="14389" xml_f="14628" txt_i="7609" txt_f="7848">. Eligibility was evaluated by medical history, concomitant medication, physical examination, electrocardiogram, blood pressure, and anamnesis. Physical activity was assessed using the International Physical Activity Questionnaire (IPAQ) [</offsets><xref ref-type="bibr" rid="CR29"><offsets xml_i="14661" xml_f="14663" txt_i="7848" txt_f="7850">29</offsets></xref><offsets xml_i="14670" xml_f="14950" txt_i="7850" txt_f="8130">]. Nutrition pattern of subjects was determined during the screening visit using a subjective, retrospective, semi-quantitative nutrition frequency questionnaire. The score ranges from 0 to 100, whereby 0 means a very good nutrition pattern and 100 a very poor nutrition pattern [</offsets><xref ref-type="bibr" rid="CR30"><offsets xml_i="14983" xml_f="14985" txt_i="8130" txt_f="8132">30</offsets></xref><offsets xml_i="14992" xml_f="15242" txt_i="8132" txt_f="8382">]. The questionnaire was developed for the German-speaking area and tested in a neutral and geriatric collective. Adequate determination of supply of micronutrient was validated by comparing with a detailed quantitative food frequency questionnaire [</offsets><xref ref-type="bibr" rid="CR30"><offsets xml_i="15275" xml_f="15277" txt_i="8382" txt_f="8384">30</offsets></xref><offsets xml_i="15284" xml_f="16266" txt_i="8384" txt_f="9366">]. A score around 50 can be interpreted as balanced nutrition. Amount of fruits and vegetables portions taken per day was asked during screening, whereby one portion was specified to be around 150 g. Subjects were requested to refrain from intake of anti-inflammatory or antioxidative drugs or supplements during the study, potentially interfering with this trial. They were asked not to change their dietary habits and physical activity during the study. The evening before the study days, subjects ate a standardized dinner low in polyphenols (noodles with cheese sauce). During the study days, they received a standardized breakfast (cereal bars) and a standardized snack (white wheat roll with butter and cheese). Amount and time were also standardized. Alcohol intake and exhaustive activities were prohibited 48 h before the study days until 96 h after the exhaustive exercise. Subjects were asked for changes in nutrition habits and sportive activity at the end of the study.</offsets><table-wrap id="Tab1"><label><offsets xml_i="16295" xml_f="16302" txt_i="9366" txt_f="9373">Table 1</offsets></label><caption><p><offsets xml_i="16322" xml_f="16348" txt_i="9373" txt_f="9399">In- and exclusion criteria</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><th><offsets xml_i="16414" xml_f="16432" txt_i="9400" txt_f="9418">Inclusion criteria</offsets></th><th><offsets xml_i="16441" xml_f="16459" txt_i="9418" txt_f="9436">Exclusion criteria</offsets></th></tr></thead><tbody><tr><td><offsets xml_i="16492" xml_f="16584" txt_i="9436" txt_f="9528">Subject is able and willing to sign the Informed Consent Form prior to screening evaluations</offsets></td><td><offsets xml_i="16593" xml_f="16848" txt_i="9529" txt_f="9784">Relevant history, presence of any medical disorder or chronic intake of medication/dietary supplements (e.g. polyphenols, anti-inflammatory or antioxidative drugs or supplements, antihypertensive drugs) potentially interfering with this study at screening</offsets></td></tr><tr><td><offsets xml_i="16866" xml_f="17058" txt_i="9785" txt_f="9977">Healthy subjects: Subject is in good physical and mental health as established by medical history, physical examination, electrocardiogram, vital signs, results of biochemistry and haematology</offsets></td><td><offsets xml_i="17067" xml_f="17168" txt_i="9978" txt_f="10079">For this study clinically relevant abnormal laboratory, vital signs or physical findings at screening</offsets></td></tr><tr><td><offsets xml_i="17186" xml_f="17199" txt_i="10080" txt_f="10093">Men and women</offsets></td><td><offsets xml_i="17208" xml_f="17251" txt_i="10094" txt_f="10137">Diabetes or serious cardiovascular diseases</offsets></td></tr><tr><td><offsets xml_i="17269" xml_f="17291" txt_i="10138" txt_f="10160">Age ≥ 22 and ≤50 years</offsets></td><td><offsets xml_i="17300" xml_f="17445" txt_i="10161" txt_f="10306">Change of dietary habits within the 2 weeks prior to screening (for instance start of a diet high in vegetables and fruits (≥ 5 portions per day)</offsets></td></tr><tr><td><offsets xml_i="17463" xml_f="17478" txt_i="10307" txt_f="10322">BMI: 19–30 kg/m</offsets><sup><offsets xml_i="17483" xml_f="17484" txt_i="10322" txt_f="10323">2</offsets></sup></td><td><offsets xml_i="17499" xml_f="17554" txt_i="10324" txt_f="10379">Diet high in vegetables and fruits ≥ 5 portions per day</offsets></td></tr><tr><td><offsets xml_i="17572" xml_f="17608" txt_i="10380" txt_f="10416">Physically active 1–3 times per week</offsets></td><td><offsets xml_i="17617" xml_f="17715" txt_i="10417" txt_f="10515">Participants anticipating a change in their lifestyle or physical activity levels during the study</offsets></td></tr><tr><td><offsets xml_i="17733" xml_f="17742" txt_i="10516" txt_f="10525">Nonsmoker</offsets></td><td><offsets xml_i="17751" xml_f="17869" txt_i="10526" txt_f="10644">Subjects not willing to abstain from intake of analgesic medication (e.g. Aspirin) 24 h prior to visit 2 until visit 5</offsets></td></tr><tr><td align="justify" rowspan="7"><offsets xml_i="17915" xml_f="17971" txt_i="10645" txt_f="10701">Able and willing to follow the study protocol procedures</offsets></td><td><offsets xml_i="17980" xml_f="18116" txt_i="10702" txt_f="10838">Subjects with history of drug, alcohol or other substances abuse, or other factors limiting their ability to co-operate during the study</offsets></td></tr><tr><td><offsets xml_i="18134" xml_f="18206" txt_i="10839" txt_f="10911">Known hypersensitivity to the study preparation or to single ingredients</offsets></td></tr><tr><td><offsets xml_i="18224" xml_f="18320" txt_i="10912" txt_f="11008">Pregnant subject or subject planning to become pregnant during the study; breast-feeding subject</offsets></td></tr><tr><td><offsets xml_i="18338" xml_f="18357" txt_i="11009" txt_f="11028">Known HIV-infection</offsets></td></tr><tr><td><offsets xml_i="18375" xml_f="18425" txt_i="11029" txt_f="11079">Known acute or chronic hepatitis B and C infection</offsets></td></tr><tr><td><offsets xml_i="18443" xml_f="18509" txt_i="11080" txt_f="11146">Blood donation within 4 weeks prior to visit 1 or during the study</offsets></td></tr><tr><td><offsets xml_i="18527" xml_f="18600" txt_i="11147" txt_f="11220">Subject involved in any clinical or food study within the preceding month</offsets></td></tr></tbody></table></table-wrap></p><p id="Par18"><offsets xml_i="18657" xml_f="19074" txt_i="11222" txt_f="11639">Subjects were randomly assigned to the study groups and stratified by gender after assessing eligibility during screening. To ensure double-blind performance, the randomization scheme was created by the sponsor using the software Randlist. All subjects, the investigator, and study staff involved in study performance, and data analysis were blinded until database lock. Disposition of subjects is summarized in Fig. </offsets><xref rid="Fig1" ref-type="fig"><offsets xml_i="19106" xml_f="19107" txt_i="11639" txt_f="11640">1</offsets></xref><offsets xml_i="19114" xml_f="19115" txt_i="11640" txt_f="11641">.</offsets><fig id="Fig1"><label><offsets xml_i="19137" xml_f="19143" txt_i="11641" txt_f="11647">Fig. 1</offsets></label><caption><p><offsets xml_i="19163" xml_f="19203" txt_i="11647" txt_f="11687">Dispostion of subjects following Concort</offsets></p></caption><graphic xlink:href="12970_2018_208_Fig1_HTML" id="MO1"></graphic></fig></p></sec><sec id="Sec5"><title><offsets xml_i="19321" xml_f="19354" txt_i="11690" txt_f="11723">Study product and supplementation</offsets></title><p id="Par19"><offsets xml_i="19376" xml_f="19573" txt_i="11724" txt_f="11921">The investigated commercial product Recoverben® (batch number 16P0007) is a proprietary lemon verbena extract obtained by water extraction out of organic dried lemon verbena leaves. Lemon verbena (</offsets><italic><offsets xml_i="19581" xml_f="19604" txt_i="11921" txt_f="11944">Aloysia citriodora (L.)</offsets></italic><offsets xml_i="19613" xml_f="20484" txt_i="11944" txt_f="12815">) is a member of the family Verbenaceae. The product is a native extract without any additives, standardized to more than 18% polyphenols. The extract is hydrophilic and can easily be dissolved in water, and has a high ORAC level of 170.000 μmol TE/100 g. Lemon verbena extract (Recoverben®) as well as the placebo were formulated in capsules, matching in size and color, and were supplied by Vital Solutions GmbH, Germany. Each capsule contained 200 mg lemon verbena extract or placebo (maltodextrin). All subjects were instructed to take two capsules daily in the morning. Products were consumed 10 days before an exhaustive exercise test, during the test day and four days after the test. The ingredient is safe for human consumption and its quality complies with EU legislation concerning hygiene, contaminants, and maximum residue levels of pesticides of foodstuff [</offsets><xref ref-type="bibr" rid="CR31"><offsets xml_i="20517" xml_f="20519" txt_i="12815" txt_f="12817">31</offsets></xref><offsets xml_i="20526" xml_f="20528" txt_i="12817" txt_f="12819">, </offsets><xref ref-type="bibr" rid="CR32"><offsets xml_i="20561" xml_f="20563" txt_i="12819" txt_f="12821">32</offsets></xref><offsets xml_i="20570" xml_f="20785" txt_i="12821" txt_f="13036">]. Additionally, the extract has been tested for and shown to be free of banned substances by a specialist anti-doping laboratory (LGC Limited, UK), therefore demonstrating suitability as a sports nutrition product.</offsets></p></sec><sec id="Sec6"><title><offsets xml_i="20817" xml_f="20845" txt_i="13038" txt_f="13066">Exhaustive exercise protocol</offsets></title><p id="Par20"><offsets xml_i="20867" xml_f="21085" txt_i="13067" txt_f="13285">In the current study, maximal eccentric loading of the lower extremity was induced by an intensive jump-protocol 10 days after the start of supplementation, which was modified based on a jump protocol used previously [</offsets><xref ref-type="bibr" rid="CR33"><offsets xml_i="21118" xml_f="21120" txt_i="13285" txt_f="13287">33</offsets></xref><offsets xml_i="21127" xml_f="21546" txt_i="13287" txt_f="13706">]. The protocol comprised 200 countermovement jumps with an additional load of 10% of the participant’s body weight. The 200 countermovement jumps were performed in 10 sets of 20 jumps every four seconds with 90 s rest between sets. Knee joint angle between the jumps had to be 90°, which was controlled by the observer. At the end of the test, rating of perceived exertion (RPE) was obtained using the Borg RPE scale [</offsets><xref ref-type="bibr" rid="CR34"><offsets xml_i="21579" xml_f="21581" txt_i="13706" txt_f="13708">34</offsets></xref><offsets xml_i="21588" xml_f="21873" txt_i="13708" txt_f="13993">]. Borg RPE scale and jump repetitions were used to ensure subjective exhaustion after exercise and to control comparability of jump protocol between groups. Massive deviation from jump protocol was defined as exclusion criteria from VCAS analysis for exclusion of confounding factors.</offsets></p></sec><sec id="Sec7"><title><offsets xml_i="21905" xml_f="21966" txt_i="13995" txt_f="14056">Muscle function testing - maximal voluntary contraction (MVC)</offsets></title><p id="Par21"><offsets xml_i="21988" xml_f="22094" txt_i="14057" txt_f="14163">Changes in muscle function appear to be the best marker for the degree of exercise induced muscle damage [</offsets><xref ref-type="bibr" rid="CR1"><offsets xml_i="22126" xml_f="22127" txt_i="14163" txt_f="14164">1</offsets></xref><offsets xml_i="22134" xml_f="22230" txt_i="14164" txt_f="14260">]. Therefore, in the current study, MVC was investigated by assessing isometric strength of the </offsets><italic><offsets xml_i="22238" xml_f="22251" txt_i="14260" txt_f="14273">M. quadriceps</offsets></italic><offsets xml_i="22260" xml_f="23597" txt_i="14273" txt_f="15610"> femoris, with 90° knee angle, using a dynamometer KM40 (2kN) from ME-Messsysteme GmbH and a strength chair from fasttwitch, TTI GmbH. Subjects were fixed in a seated position with a hip belt, had their arms crossed in front of the chest, and had the free leg hanging without contact to any surface to reduce support by other body parts during the test. Before each measurement, subjects performed a 3 min warm-up (level 7, 70 rpm) on a cycle ergometer (Crane Power Studio Ergometer). The strength measurement was performed for the dominant leg. This was identified at screening by a shove-test, where the subject was pushed unexpected by the observer and the leg which was used by subject to balance was defined as dominant leg. All examinations were performed in triplicates, immediately before and 3, 24, and 48 h after the exhaustive exercise protocol. The highest value was used for analysis. Subjects were familiarized to the measurement at screening. For each subject, the settings of the strength chair (position of back rest, leg rest and position of measurement arm) were documented. All further measurements were performed with the individual settings. First measurement was performed during screening visit to avoid training effects during study visits. Variability was checked between screening and pre-exercise measurement.</offsets></p></sec><sec id="Sec8"><title><offsets xml_i="23629" xml_f="23654" txt_i="15612" txt_f="15637">Perceived muscle soreness</offsets></title><p><offsets xml_i="23665" xml_f="23722" txt_i="15638" txt_f="15695">Muscle soreness was measured using two different methods.</offsets></p><sec id="Sec9"><title><offsets xml_i="23748" xml_f="23775" txt_i="15696" txt_f="15723">Movement induced pain (VAS)</offsets></title><p id="Par22"><offsets xml_i="23797" xml_f="24239" txt_i="15724" txt_f="16166">Subjects were asked to sit down into and get up from a chair and to rate the pain they experienced in doing so using a 100 mm visual analogue scale (VAS), which consisted of a from zero mm (no pain) to 100 mm (worst imaginable pain). This assessment was conducted immediately before and 3, 24, 48, 72, and 96 h after the exhaustive exercise protocol. Using VAS is frequently described in literature for assessing acute exercise induced pain [</offsets><xref ref-type="bibr" rid="CR2"><offsets xml_i="24271" xml_f="24272" txt_i="16166" txt_f="16167">2</offsets></xref><offsets xml_i="24279" xml_f="24281" txt_i="16167" txt_f="16169">, </offsets><xref ref-type="bibr" rid="CR33"><offsets xml_i="24314" xml_f="24316" txt_i="16169" txt_f="16171">33</offsets></xref><offsets xml_i="24323" xml_f="24325" txt_i="16171" txt_f="16173">, </offsets><xref ref-type="bibr" rid="CR35"><offsets xml_i="24358" xml_f="24360" txt_i="16173" txt_f="16175">35</offsets></xref><offsets xml_i="24367" xml_f="24369" txt_i="16175" txt_f="16177">].</offsets></p></sec><sec id="Sec10"><title><offsets xml_i="24402" xml_f="24435" txt_i="16179" txt_f="16212">Retrospective pain (Likert scale)</offsets></title><p id="Par24"><offsets xml_i="24457" xml_f="24739" txt_i="16213" txt_f="16495">A seven point retrospective pain questionnaire (7 point Likert-scale for muscle soreness) by Vickers et al. was used to evaluate retrospective perceived pain during daily life activities with zero “a complete absence of pain” and six “a severe pain that limits my ability to move” [</offsets><xref ref-type="bibr" rid="CR36"><offsets xml_i="24772" xml_f="24774" txt_i="16495" txt_f="16497">36</offsets></xref><offsets xml_i="24781" xml_f="24924" txt_i="16497" txt_f="16640">]. The subjects were asked to answer the questionnaire immediately before the exhaustive exercise and 24, 48, 72, and 96 h after the jump test.</offsets></p></sec></sec><sec id="Sec11"><title><offsets xml_i="24963" xml_f="24983" txt_i="16643" txt_f="16663">Biochemical analysis</offsets></title><p id="Par25"><offsets xml_i="25005" xml_f="25139" txt_i="16664" txt_f="16798">Different biomarkers were analyzed to evaluate muscle damage and antioxidative capacity to describe exercise-induced oxidative stress.</offsets></p><sec id="Sec12"><title><offsets xml_i="25166" xml_f="25186" txt_i="16799" txt_f="16819">Creatine kinase (CK)</offsets></title><p id="Par26"><offsets xml_i="25208" xml_f="25536" txt_i="16820" txt_f="17148">CK is a biomarker for muscle damage typically increased after intense exervcise. In our study, CK was determined from blood samples obtained before and 3, 24, and 48 h after the exhausting exercise protocol. Analyses were carried out at Synlab Medizinisches Versorgungszentrum Leinfelden using an enzymatic-kinetic test method [</offsets><xref ref-type="bibr" rid="CR37"><offsets xml_i="25569" xml_f="25571" txt_i="17148" txt_f="17150">37</offsets></xref><offsets xml_i="25578" xml_f="25580" txt_i="17150" txt_f="17152">].</offsets></p></sec><sec id="Sec13"><title><offsets xml_i="25613" xml_f="25641" txt_i="17154" txt_f="17182">Glutathione peroxidase (GPx)</offsets></title><p id="Par27"><offsets xml_i="25663" xml_f="25952" txt_i="17183" txt_f="17472">Exercise training is accompanied with oxidative stress via production of reactive oxygen species (ROS), and modulating the endogenous antioxidant defense system, including GPx. In a healthy organism, exercise induces GPx levels, inactivating ROS and maintain them in physiological levels [</offsets><xref ref-type="bibr" rid="CR38"><offsets xml_i="25985" xml_f="25987" txt_i="17472" txt_f="17474">38</offsets></xref><offsets xml_i="25994" xml_f="25996" txt_i="17474" txt_f="17476">, </offsets><xref ref-type="bibr" rid="CR39"><offsets xml_i="26029" xml_f="26031" txt_i="17476" txt_f="17478">39</offsets></xref><offsets xml_i="26038" xml_f="26220" txt_i="17478" txt_f="17660">]. The determination in plasma (GPxP) was carried out at the study lab via GPx-Assay-Kit (Cayman Chemical Company, Ann Arbor, MI, USA) pre-exercise and 3, 24, and 48 h post exercise.</offsets></p></sec><sec id="Sec14"><title><offsets xml_i="26253" xml_f="26273" txt_i="17662" txt_f="17682">Interleukin-6 (IL-6)</offsets></title><p id="Par28"><offsets xml_i="26295" xml_f="26473" txt_i="17683" txt_f="17861">IL-6 is a multifunctional cytokine involved in pro- as well as anti-inflammatory processes. Exercise-induced IL6 response is dependent on intensity and duration of the exercise [</offsets><xref ref-type="bibr" rid="CR40"><offsets xml_i="26506" xml_f="26508" txt_i="17861" txt_f="17863">40</offsets></xref><offsets xml_i="26515" xml_f="26704" txt_i="17863" txt_f="18048">]. The determination in serum was carried out at the study lab via Quantikine® HS Human IL-6 Immunoassay Kit (R&amp;D Systems, Inc., MN, USA) pre-exercise and 3, 24, and 48 h post exercise.</offsets></p></sec></sec><sec id="Sec15"><title><offsets xml_i="26743" xml_f="26766" txt_i="18051" txt_f="18074">Safety and tolerability</offsets></title><p id="Par29"><offsets xml_i="26788" xml_f="27211" txt_i="18075" txt_f="18498">At each visit, changes in physical conditions since the last visit were reviewed with subjects. Based on entries in subject diaries, complete blood count, and adverse events were assessed. Tolerability of the study product was assessed 96 h after exercise, and at the end of study. The subjects rated overall tolerability by selecting out of three categories: “well tolerated”, “slightly unpleasant”, and “very unpleasant”.</offsets></p></sec><sec id="Sec16"><title><offsets xml_i="27244" xml_f="27254" txt_i="18500" txt_f="18510">Statistics</offsets></title><p id="Par30"><offsets xml_i="27276" xml_f="27444" txt_i="18511" txt_f="18679">The study was planned as an exploratory trial. Sample size was calculated based on different studies observing the effects of lemon verbena and using a similar design [</offsets><xref ref-type="bibr" rid="CR19"><offsets xml_i="27477" xml_f="27479" txt_i="18679" txt_f="18681">19</offsets></xref><offsets xml_i="27486" xml_f="27488" txt_i="18681" txt_f="18683">, </offsets><xref ref-type="bibr" rid="CR35"><offsets xml_i="27521" xml_f="27523" txt_i="18683" txt_f="18685">35</offsets></xref><offsets xml_i="27530" xml_f="27965" txt_i="18685" txt_f="19120">]. Therefore, a sample size calculation was performed with effect size f = 0.2, significance level 0.05, power 80%, two number of groups and four measurement time points (pre, 2 h, 24 h, 48 h), correlation among repeated measures 0.5 and with nonsphericity correction 1. With these suggestions, a total sample size of 36 subjects was calculated. Considering a drop-out rate of 10%, 40 subjects were planned to be included in the study.</offsets></p><p id="Par31"><offsets xml_i="27983" xml_f="28179" txt_i="19121" txt_f="19317">Objectives were the difference of muscle strength, muscle soreness, retrospective pain, CK, IL-6, and glutathione peroxidase after exhaustive exercise under lemon verbena in comparison to placebo.</offsets></p><p id="Par32"><offsets xml_i="28197" xml_f="29384" txt_i="19318" txt_f="20499">Data were analyzed using SAS Version 9.3 and GraphPad Prism Version 5.04. All statistical tests were performed two-sided. Significance level was set to 0.05. For evaluation of treatment effects, a linear mixed model with repeated measures was used. For retrospective pain, a generalized linear mixed model with Poisson-distribution for count data was used. Due to explorative data analysis, no correction for multiple comparison was performed. Gender, its interaction with treatment and the respective pre value was included as covariates for the biomarkers and MVC. For movement induced pain and retrospective pain only gender and its interaction with treatment were defined as covariates. Changes within groups were assessed using one way ANOVA or Friedmann test, as appropriate. All efficacy parameters were checked for baseline differences. Results presented below refer on valid case analysis set (VCAS). VCAS criteria were pre-defined in the protocol: missing data, adverse events or concomitant medication interfering with study results, extreme outliers, and major protocol violation (compliance &lt;85%, &gt; 115%, drop outs / withdrawals, major deviation of study performance).</offsets></p></sec></sec><sec id="Sec17"><title><offsets xml_i="29423" xml_f="29430" txt_i="20502" txt_f="20509">Results</offsets></title><sec id="Sec18"><title><offsets xml_i="29461" xml_f="29482" txt_i="20510" txt_f="20531">Group characteristics</offsets></title><p id="Par33"><offsets xml_i="29504" xml_f="29897" txt_i="20532" txt_f="20925">Out of 44 subjects allocated to intervention, 40 subjects (19 men and 21 women) completed the study according to the protocol (full analysis set; FAS). Four subjects dropped out after start of supplementation and before efficacy testing. Three of these suffered from a common cold, which did not allow them to perform the exhaustive exercise test, and one dropped out due to personal decision.</offsets></p><p id="Par34"><offsets xml_i="29915" xml_f="30380" txt_i="20926" txt_f="21391">Thirty-seven subjects were analyzed for valid case analysis set (VCAS). One subject had a strong common cold during the exhaustive exercise test, which may have influenced biomarker results. Another subject did not meet compliance criteria for study product intake and the third subject had major deviation of the exhaustive exercise protocol. As these three subjects did meet exclusion criteria for VCAS analysis, they were not considered in final analysis (VCAS).</offsets></p><p id="Par35"><offsets xml_i="30398" xml_f="30574" txt_i="21392" txt_f="21568">Gender, age, BMI, blood routine markers, and blood pressure did not differ significantly between the groups prior to the study. Subject characteristics are summarized in Table </offsets><xref rid="Tab2" ref-type="table"><offsets xml_i="30608" xml_f="30609" txt_i="21568" txt_f="21569">2</offsets></xref><offsets xml_i="30616" xml_f="30763" txt_i="21569" txt_f="21716">. The nutrition frequency questionnaire scores were 45.35 ± 10.51 points in the lemon verbena group and 42.65 ± 11.33 points in the placebo group (</offsets><italic><offsets xml_i="30771" xml_f="30772" txt_i="21716" txt_f="21717">p</offsets></italic><offsets xml_i="30781" xml_f="31504" txt_i="21717" txt_f="22437"> = 0.4597). Most subjects consumed between two and four portions fruits plus vegetables per day (lemon verbena: 82%, placebo: 70%). Intake of fruit and vegetables, as supplier for polyphenols, were comparable between groups. The protocol compliance of study product intake was very good. For VCAS, all subjects met the compliance criterion ≥85% and ≤115% of study preparation consumed (lemon verbena group: 102 ± 5%, placebo: 101 ± 2%). For FAS, one subject had a compliance &gt;115% since much less products remained, bringing up uncertainty about correct intake, which was the reason for exclusion from VCAS. Borg scale data after exhaustive exercise and jump repetitions were not significantly different between groups (</offsets><italic><offsets xml_i="31512" xml_f="31513" txt_i="22437" txt_f="22438">p</offsets></italic><offsets xml_i="31522" xml_f="31533" txt_i="22438" txt_f="22449"> = 0.8997, </offsets><italic><offsets xml_i="31541" xml_f="31542" txt_i="22449" txt_f="22450">p</offsets></italic><offsets xml_i="31551" xml_f="31552" txt_i="22450" txt_f="22451"> </offsets><table-wrap id="Tab2"><label><offsets xml_i="31581" xml_f="31588" txt_i="22451" txt_f="22458">Table 2</offsets></label><caption><p><offsets xml_i="31608" xml_f="31654" txt_i="22458" txt_f="22504">Subject characteristics at screening for FAS (</offsets><italic><offsets xml_i="31662" xml_f="31663" txt_i="22504" txt_f="22505">N</offsets></italic><offsets xml_i="31672" xml_f="31696" txt_i="22505" txt_f="22529"> = 40, 19 men, 21 women)</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><th><offsets xml_i="31762" xml_f="31771" txt_i="22530" txt_f="22539">Parameter</offsets><break></break><offsets xml_i="31786" xml_f="31792" txt_i="22539" txt_f="22545">[unit]</offsets></th><th></th><th><offsets xml_i="31810" xml_f="31823" txt_i="22545" txt_f="22558">Lemon verbena</offsets><break></break><offsets xml_i="31838" xml_f="31839" txt_i="22558" txt_f="22559">(</offsets><italic><offsets xml_i="31847" xml_f="31848" txt_i="22559" txt_f="22560">N</offsets></italic><offsets xml_i="31857" xml_f="31882" txt_i="22560" txt_f="22585"> = 20 59% men, 41% women)</offsets></th><th><offsets xml_i="31891" xml_f="31898" txt_i="22585" txt_f="22592">Placebo</offsets><break></break><offsets xml_i="31913" xml_f="31914" txt_i="22592" txt_f="22593">(</offsets><italic><offsets xml_i="31922" xml_f="31923" txt_i="22593" txt_f="22594">N</offsets></italic><offsets xml_i="31932" xml_f="31957" txt_i="22594" txt_f="22619"> = 20 40% men, 60% women)</offsets></th><th><offsets xml_i="31966" xml_f="32000" txt_i="22619" txt_f="22653">Inclusion criteria/Reference range</offsets></th></tr></thead><tbody><tr><td rowspan="2"><offsets xml_i="32045" xml_f="32048" txt_i="22653" txt_f="22656">Age</offsets><break></break><offsets xml_i="32063" xml_f="32070" txt_i="22656" txt_f="22663">[years]</offsets></td><td><offsets xml_i="32079" xml_f="32083" txt_i="22664" txt_f="22668">Mean</offsets></td><td><offsets xml_i="32092" xml_f="32096" txt_i="22669" txt_f="22673">31.7</offsets></td><td><offsets xml_i="32105" xml_f="32109" txt_i="22674" txt_f="22678">30.6</offsets></td><td align="center" rowspan="2"><offsets xml_i="32145" xml_f="32150" txt_i="22679" txt_f="22684">22–50</offsets></td></tr><tr><td><offsets xml_i="32168" xml_f="32170" txt_i="22685" txt_f="22687">Sd</offsets></td><td><offsets xml_i="32179" xml_f="32182" txt_i="22688" txt_f="22691">8.8</offsets></td><td><offsets xml_i="32191" xml_f="32194" txt_i="22692" txt_f="22695">9.3</offsets></td></tr><tr><td rowspan="2"><offsets xml_i="32224" xml_f="32227" txt_i="22696" txt_f="22699">BMI</offsets><break></break><offsets xml_i="32242" xml_f="32247" txt_i="22699" txt_f="22704">[kg/m</offsets><sup><offsets xml_i="32252" xml_f="32253" txt_i="22704" txt_f="22705">2</offsets></sup><offsets xml_i="32259" xml_f="32260" txt_i="22705" txt_f="22706">]</offsets></td><td><offsets xml_i="32269" xml_f="32273" txt_i="22707" txt_f="22711">Mean</offsets></td><td><offsets xml_i="32282" xml_f="32287" txt_i="22712" txt_f="22717">22.67</offsets></td><td><offsets xml_i="32296" xml_f="32300" txt_i="22718" txt_f="22722">23.0</offsets></td><td align="center" rowspan="2"><offsets xml_i="32336" xml_f="32341" txt_i="22723" txt_f="22728">19–30</offsets></td></tr><tr><td><offsets xml_i="32359" xml_f="32361" txt_i="22729" txt_f="22731">Sd</offsets></td><td><offsets xml_i="32370" xml_f="32373" txt_i="22732" txt_f="22735">2.3</offsets></td><td><offsets xml_i="32382" xml_f="32385" txt_i="22736" txt_f="22739">2.5</offsets></td></tr><tr><td rowspan="2"><offsets xml_i="32415" xml_f="32423" txt_i="22740" txt_f="22748">Activity</offsets><break></break><offsets xml_i="32438" xml_f="32452" txt_i="22748" txt_f="22762">[MET min/week]</offsets></td><td><offsets xml_i="32461" xml_f="32465" txt_i="22763" txt_f="22767">Mean</offsets></td><td><offsets xml_i="32474" xml_f="32478" txt_i="22768" txt_f="22772">3209</offsets></td><td><offsets xml_i="32487" xml_f="32493" txt_i="22773" txt_f="22779">2470.0</offsets></td><td align="center" rowspan="2"><offsets xml_i="32529" xml_f="32530" txt_i="22780" txt_f="22781">–</offsets></td></tr><tr><td><offsets xml_i="32548" xml_f="32550" txt_i="22782" txt_f="22784">Sd</offsets></td><td><offsets xml_i="32559" xml_f="32565" txt_i="22785" txt_f="22791">3957.0</offsets></td><td><offsets xml_i="32574" xml_f="32578" txt_i="22792" txt_f="22796">2521</offsets></td></tr><tr><td rowspan="2"><offsets xml_i="32608" xml_f="32612" txt_i="22797" txt_f="22801">CHOL</offsets><break></break><offsets xml_i="32627" xml_f="32634" txt_i="22801" txt_f="22808">[mg/dL]</offsets></td><td><offsets xml_i="32643" xml_f="32647" txt_i="22809" txt_f="22813">Mean</offsets></td><td><offsets xml_i="32656" xml_f="32661" txt_i="22814" txt_f="22819">172.5</offsets></td><td><offsets xml_i="32670" xml_f="32675" txt_i="22820" txt_f="22825">180.0</offsets></td><td align="center" rowspan="2"><offsets xml_i="32711" xml_f="32718" txt_i="22826" txt_f="22833">100–200</offsets></td></tr><tr><td><offsets xml_i="32736" xml_f="32738" txt_i="22834" txt_f="22836">Sd</offsets></td><td><offsets xml_i="32747" xml_f="32751" txt_i="22837" txt_f="22841">23.0</offsets></td><td><offsets xml_i="32760" xml_f="32765" txt_i="22842" txt_f="22847">31.85</offsets></td></tr><tr><td rowspan="2"><offsets xml_i="32795" xml_f="32797" txt_i="22848" txt_f="22850">TG</offsets><break></break><offsets xml_i="32812" xml_f="32819" txt_i="22850" txt_f="22857">[mg/dL]</offsets></td><td><offsets xml_i="32828" xml_f="32832" txt_i="22858" txt_f="22862">Mean</offsets></td><td><offsets xml_i="32841" xml_f="32846" txt_i="22863" txt_f="22868">89.68</offsets></td><td><offsets xml_i="32855" xml_f="32860" txt_i="22869" txt_f="22874">82.14</offsets></td><td align="center" rowspan="2"><offsets xml_i="32896" xml_f="32903" txt_i="22875" txt_f="22879">&lt;160</offsets></td></tr><tr><td><offsets xml_i="32921" xml_f="32923" txt_i="22880" txt_f="22882">Sd</offsets></td><td><offsets xml_i="32932" xml_f="32937" txt_i="22883" txt_f="22888">43.53</offsets></td><td><offsets xml_i="32946" xml_f="32951" txt_i="22889" txt_f="22894">24.71</offsets></td></tr><tr><td rowspan="2"><offsets xml_i="32981" xml_f="32984" txt_i="22895" txt_f="22898">HDL</offsets><break></break><offsets xml_i="32999" xml_f="33006" txt_i="22898" txt_f="22905">[mg/dL]</offsets></td><td><offsets xml_i="33015" xml_f="33019" txt_i="22906" txt_f="22910">Mean</offsets></td><td><offsets xml_i="33028" xml_f="33033" txt_i="22911" txt_f="22916">58.91</offsets></td><td><offsets xml_i="33042" xml_f="33047" txt_i="22917" txt_f="22922">58.95</offsets></td><td align="center" rowspan="2"><offsets xml_i="33083" xml_f="33089" txt_i="22923" txt_f="22926">&gt;40</offsets></td></tr><tr><td><offsets xml_i="33107" xml_f="33109" txt_i="22927" txt_f="22929">Sd</offsets></td><td><offsets xml_i="33118" xml_f="33123" txt_i="22930" txt_f="22935">6.487</offsets></td><td><offsets xml_i="33132" xml_f="33137" txt_i="22936" txt_f="22941">14.24</offsets></td></tr><tr><td rowspan="2"><offsets xml_i="33167" xml_f="33170" txt_i="22942" txt_f="22945">LDL</offsets><break></break><offsets xml_i="33185" xml_f="33192" txt_i="22945" txt_f="22952">[mg/dL]</offsets></td><td><offsets xml_i="33201" xml_f="33205" txt_i="22953" txt_f="22957">Mean</offsets></td><td><offsets xml_i="33214" xml_f="33219" txt_i="22958" txt_f="22963">93.86</offsets></td><td><offsets xml_i="33228" xml_f="33233" txt_i="22964" txt_f="22969">109.5</offsets></td><td align="center" rowspan="2"><offsets xml_i="33269" xml_f="33276" txt_i="22970" txt_f="22974">&lt;150</offsets></td></tr><tr><td><offsets xml_i="33294" xml_f="33296" txt_i="22975" txt_f="22977">Sd</offsets></td><td><offsets xml_i="33305" xml_f="33310" txt_i="22978" txt_f="22983">16.32</offsets></td><td><offsets xml_i="33319" xml_f="33323" txt_i="22984" txt_f="22988">28.7</offsets></td></tr><tr><td rowspan="2"><offsets xml_i="33353" xml_f="33360" txt_i="22989" txt_f="22996">Glucose</offsets><break></break><offsets xml_i="33375" xml_f="33382" txt_i="22996" txt_f="23003">[mg/dL]</offsets></td><td><offsets xml_i="33391" xml_f="33395" txt_i="23004" txt_f="23008">Mean</offsets></td><td><offsets xml_i="33404" xml_f="33409" txt_i="23009" txt_f="23014">87.55</offsets></td><td><offsets xml_i="33418" xml_f="33423" txt_i="23015" txt_f="23020">86.14</offsets></td><td align="center" rowspan="2"><offsets xml_i="33459" xml_f="33465" txt_i="23021" txt_f="23027">60–100</offsets></td></tr><tr><td><offsets xml_i="33483" xml_f="33485" txt_i="23028" txt_f="23030">Sd</offsets></td><td><offsets xml_i="33494" xml_f="33499" txt_i="23031" txt_f="23036">8.405</offsets></td><td><offsets xml_i="33508" xml_f="33512" txt_i="23037" txt_f="23041">4.96</offsets></td></tr><tr><td rowspan="2"><offsets xml_i="33542" xml_f="33545" txt_i="23042" txt_f="23045">SBP</offsets><break></break><offsets xml_i="33560" xml_f="33566" txt_i="23045" txt_f="23051">[mmhg]</offsets></td><td><offsets xml_i="33575" xml_f="33579" txt_i="23052" txt_f="23056">Mean</offsets></td><td><offsets xml_i="33588" xml_f="33593" txt_i="23057" txt_f="23062">121.6</offsets></td><td><offsets xml_i="33602" xml_f="33607" txt_i="23063" txt_f="23068">121.6</offsets></td><td align="center" rowspan="2"><offsets xml_i="33643" xml_f="33650" txt_i="23069" txt_f="23076">120–129</offsets></td></tr><tr><td><offsets xml_i="33668" xml_f="33670" txt_i="23077" txt_f="23079">Sd</offsets></td><td><offsets xml_i="33679" xml_f="33683" txt_i="23080" txt_f="23084">12.8</offsets></td><td><offsets xml_i="33692" xml_f="33696" txt_i="23085" txt_f="23089">12.8</offsets></td></tr><tr><td rowspan="2"><offsets xml_i="33726" xml_f="33729" txt_i="23090" txt_f="23093">DBP</offsets><break></break><offsets xml_i="33744" xml_f="33750" txt_i="23093" txt_f="23099">[mmhg]</offsets></td><td><offsets xml_i="33759" xml_f="33763" txt_i="23100" txt_f="23104">Mean</offsets></td><td><offsets xml_i="33772" xml_f="33776" txt_i="23105" txt_f="23109">75.8</offsets></td><td><offsets xml_i="33785" xml_f="33789" txt_i="23110" txt_f="23114">70.6</offsets></td><td align="center" rowspan="2"><offsets xml_i="33825" xml_f="33830" txt_i="23115" txt_f="23120">80–84</offsets></td></tr><tr><td><offsets xml_i="33848" xml_f="33850" txt_i="23121" txt_f="23123">Sd</offsets></td><td><offsets xml_i="33859" xml_f="33862" txt_i="23124" txt_f="23127">8.8</offsets></td><td><offsets xml_i="33871" xml_f="33875" txt_i="23128" txt_f="23132">10.5</offsets></td></tr></tbody></table><table-wrap-foot><p><italic><offsets xml_i="33929" xml_f="33932" txt_i="23133" txt_f="23136">BMI</offsets></italic><offsets xml_i="33941" xml_f="33959" txt_i="23136" txt_f="23154"> body mass index, </offsets><italic><offsets xml_i="33967" xml_f="33970" txt_i="23154" txt_f="23157">MET</offsets></italic><offsets xml_i="33979" xml_f="34010" txt_i="23157" txt_f="23188"> metabolic equivalent of task, </offsets><italic><offsets xml_i="34018" xml_f="34022" txt_i="23188" txt_f="23192">CHOL</offsets></italic><offsets xml_i="34031" xml_f="34045" txt_i="23192" txt_f="23206"> cholesterol, </offsets><italic><offsets xml_i="34053" xml_f="34055" txt_i="23206" txt_f="23208">TG</offsets></italic><offsets xml_i="34064" xml_f="34080" txt_i="23208" txt_f="23224"> triglycerides, </offsets><italic><offsets xml_i="34088" xml_f="34091" txt_i="23224" txt_f="23227">HDL</offsets></italic><offsets xml_i="34100" xml_f="34127" txt_i="23227" txt_f="23254"> high-density lipoprotein, </offsets><italic><offsets xml_i="34135" xml_f="34138" txt_i="23254" txt_f="23257">LDL</offsets></italic><offsets xml_i="34147" xml_f="34173" txt_i="23257" txt_f="23283"> low-density lipoprotein, </offsets><italic><offsets xml_i="34181" xml_f="34184" txt_i="23283" txt_f="23286">SBP</offsets></italic><offsets xml_i="34193" xml_f="34219" txt_i="23286" txt_f="23312"> systolic blood pressure, </offsets><italic><offsets xml_i="34227" xml_f="34230" txt_i="23312" txt_f="23315">DBP</offsets></italic><offsets xml_i="34239" xml_f="34264" txt_i="23315" txt_f="23340"> diastolic blood pressure</offsets></p></table-wrap-foot></table-wrap></p></sec><sec id="Sec19"><title><offsets xml_i="34332" xml_f="34387" txt_i="23343" txt_f="23398">Muscle function testing - maximal voluntary contraction</offsets></title><p id="Par36"><offsets xml_i="34409" xml_f="34513" txt_i="23399" txt_f="23503">MVC was significantly less reduced after exercise in the lemon verbena group than in the placebo group (</offsets><italic><offsets xml_i="34521" xml_f="34522" txt_i="23503" txt_f="23504">p</offsets></italic><offsets xml_i="34531" xml_f="34573" txt_i="23504" txt_f="23546"> = 0.0311), with significant time effect (</offsets><italic><offsets xml_i="34581" xml_f="34582" txt_i="23546" txt_f="23547">p</offsets></italic><offsets xml_i="34591" xml_f="34609" txt_i="23547" txt_f="23565"> = 0.0051), (Fig. </offsets><xref rid="Fig2" ref-type="fig"><offsets xml_i="34641" xml_f="34642" txt_i="23565" txt_f="23566">2</offsets></xref><offsets xml_i="34649" xml_f="34657" txt_i="23566" txt_f="23574">, Table </offsets><xref rid="Tab3" ref-type="table"><offsets xml_i="34691" xml_f="34692" txt_i="23574" txt_f="23575">3</offsets></xref><offsets xml_i="34699" xml_f="34865" txt_i="23575" txt_f="23741">). In the lemon verbena group, muscle strength was completely back to baseline after 48 h, whereas strength was still reduced at that time point in the placebo group.</offsets><fig id="Fig2"><label><offsets xml_i="34887" xml_f="34893" txt_i="23741" txt_f="23747">Fig. 2</offsets></label><caption><p><offsets xml_i="34913" xml_f="34990" txt_i="23747" txt_f="23824">Maximal voluntary contraction. Delta MVC [N] (Mean ± 95% CI; product effect: </offsets><italic><offsets xml_i="34998" xml_f="34999" txt_i="23824" txt_f="23825">p</offsets></italic><offsets xml_i="35008" xml_f="35110" txt_i="23825" txt_f="23923"> = 0.0311) * indicating significance against baseline; &amp; indicating significant group differeneces</offsets></p></caption><graphic xlink:href="12970_2018_208_Fig2_HTML" id="MO2"></graphic></fig><table-wrap id="Tab3"><label><offsets xml_i="35225" xml_f="35232" txt_i="23924" txt_f="23931">Table 3</offsets></label><caption><p><offsets xml_i="35252" xml_f="35632" txt_i="23931" txt_f="24311">Statistical results within (one way-ANOVA) and between groups (Linear mixed models with repeated measures or in case of Ret. pain generalized linear mixed model with poisson distribution for count data) for maximal voluntary contraction (MVC), movement induced pain (VAS), retrospective pain (Ret. pain), creatin kinase (CK), gluthation peroxidase (GPxP) and interleukine-6 (IL-6)</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"></th><th colspan="2"><offsets xml_i="35731" xml_f="35743" txt_i="24312" txt_f="24324">Within group</offsets></th><th colspan="2"><offsets xml_i="35764" xml_f="35777" txt_i="24324" txt_f="24337">Between group</offsets></th></tr><tr><th><offsets xml_i="35795" xml_f="35808" txt_i="24337" txt_f="24350">Lemon verbena</offsets></th><th><offsets xml_i="35817" xml_f="35824" txt_i="24350" txt_f="24357">Placebo</offsets></th><th><offsets xml_i="35833" xml_f="35847" txt_i="24357" txt_f="24371">Product effect</offsets></th><th><offsets xml_i="35856" xml_f="35867" txt_i="24371" txt_f="24382">Time effect</offsets></th></tr></thead><tbody><tr><td><offsets xml_i="35900" xml_f="35903" txt_i="24382" txt_f="24385">MVC</offsets></td><td><offsets xml_i="35912" xml_f="35917" txt_i="24386" txt_f="24391">0.005</offsets></td><td><offsets xml_i="35926" xml_f="35936" txt_i="24392" txt_f="24399">&lt;0.0001</offsets></td><td><offsets xml_i="35945" xml_f="35951" txt_i="24400" txt_f="24406">0.0311</offsets></td><td><offsets xml_i="35960" xml_f="35966" txt_i="24407" txt_f="24413">0.0051</offsets></td></tr><tr><td><offsets xml_i="35984" xml_f="35987" txt_i="24414" txt_f="24417">VAS</offsets></td><td><offsets xml_i="35996" xml_f="36006" txt_i="24418" txt_f="24425">&lt;0.0001</offsets></td><td><offsets xml_i="36015" xml_f="36025" txt_i="24426" txt_f="24433">&lt;0.0001</offsets></td><td><offsets xml_i="36034" xml_f="36040" txt_i="24434" txt_f="24440">0.0788</offsets></td><td><offsets xml_i="36049" xml_f="36059" txt_i="24441" txt_f="24448">&lt;0.0001</offsets></td></tr><tr><td><offsets xml_i="36077" xml_f="36086" txt_i="24449" txt_f="24458">Ret. pain</offsets></td><td><offsets xml_i="36095" xml_f="36105" txt_i="24459" txt_f="24466">&lt;0.0001</offsets></td><td><offsets xml_i="36114" xml_f="36124" txt_i="24467" txt_f="24474">&lt;0.0001</offsets></td><td><offsets xml_i="36133" xml_f="36138" txt_i="24475" txt_f="24480">0.782</offsets></td><td><offsets xml_i="36147" xml_f="36157" txt_i="24481" txt_f="24488">&lt;0.0001</offsets></td></tr><tr><td><offsets xml_i="36175" xml_f="36177" txt_i="24489" txt_f="24491">CK</offsets></td><td><offsets xml_i="36186" xml_f="36196" txt_i="24492" txt_f="24499">&lt;0.0001</offsets></td><td><offsets xml_i="36205" xml_f="36215" txt_i="24500" txt_f="24507">&lt;0.0001</offsets></td><td><offsets xml_i="36224" xml_f="36230" txt_i="24508" txt_f="24514">0.9412</offsets></td><td><offsets xml_i="36239" xml_f="36249" txt_i="24515" txt_f="24522">&lt;0.0001</offsets></td></tr><tr><td><offsets xml_i="36267" xml_f="36271" txt_i="24523" txt_f="24527">GPxP</offsets></td><td><offsets xml_i="36280" xml_f="36285" txt_i="24528" txt_f="24533">0.204</offsets></td><td><offsets xml_i="36294" xml_f="36300" txt_i="24534" txt_f="24540">0.5895</offsets></td><td><offsets xml_i="36309" xml_f="36315" txt_i="24541" txt_f="24547">0.0681</offsets></td><td><offsets xml_i="36324" xml_f="36330" txt_i="24548" txt_f="24554">0.0624</offsets></td></tr></tbody></table></table-wrap></p></sec><sec id="Sec20"><title><offsets xml_i="36402" xml_f="36427" txt_i="24557" txt_f="24582">Perceived muscle soreness</offsets></title><p id="Par38"><offsets xml_i="36449" xml_f="36534" txt_i="24583" txt_f="24668">Movement induced pain (VAS) in the lemon verbena group was less pronounced by trend (</offsets><italic><offsets xml_i="36542" xml_f="36543" txt_i="24668" txt_f="24669">p</offsets></italic><offsets xml_i="36552" xml_f="36595" txt_i="24669" txt_f="24712"> = 0.0788) with a significant time effect (</offsets><italic><offsets xml_i="36603" xml_f="36604" txt_i="24712" txt_f="24713">p</offsets></italic><offsets xml_i="36613" xml_f="36668" txt_i="24713" txt_f="24765"> &lt; 0.0001) in comparison to the placebo group (Fig. </offsets><xref rid="Fig3" ref-type="fig"><offsets xml_i="36700" xml_f="36701" txt_i="24765" txt_f="24766">3</offsets></xref><offsets xml_i="36708" xml_f="36716" txt_i="24766" txt_f="24774">, Table </offsets><xref rid="Tab3" ref-type="table"><offsets xml_i="36750" xml_f="36751" txt_i="24774" txt_f="24775">3</offsets></xref><offsets xml_i="36758" xml_f="36847" txt_i="24775" txt_f="24864">). Retrospective pain was comparable between groups without significant difference (Fig. </offsets><xref rid="Fig4" ref-type="fig"><offsets xml_i="36879" xml_f="36880" txt_i="24864" txt_f="24865">4</offsets></xref><offsets xml_i="36887" xml_f="37002" txt_i="24865" txt_f="24980">). Both groups showed significant increase in soreness 24, 48, and 72 h after exercise in relation to pre-exercise.</offsets><fig id="Fig3"><label><offsets xml_i="37024" xml_f="37030" txt_i="24980" txt_f="24986">Fig. 3</offsets></label><caption><p><offsets xml_i="37050" xml_f="37138" txt_i="24986" txt_f="25074">Movement induced pain. Movement induced pain (VAS) [cm] (Mean ± 95% CI; product effect: </offsets><italic><offsets xml_i="37146" xml_f="37147" txt_i="25074" txt_f="25075">p</offsets></italic><offsets xml_i="37156" xml_f="37209" txt_i="25075" txt_f="25128"> = 0.0788) * indicating significance against baseline</offsets></p></caption><graphic xlink:href="12970_2018_208_Fig3_HTML" id="MO3"></graphic></fig><fig id="Fig4"><label><offsets xml_i="37317" xml_f="37323" txt_i="25129" txt_f="25135">Fig. 4</offsets></label><caption><p><offsets xml_i="37343" xml_f="37422" txt_i="25135" txt_f="25214">Retrospective pain. Retrospective pain [score] (Mean ± 95% CI; product effect: </offsets><italic><offsets xml_i="37430" xml_f="37431" txt_i="25214" txt_f="25215">p</offsets></italic><offsets xml_i="37440" xml_f="37493" txt_i="25215" txt_f="25268"> = 0.7820) * indicating significance against baseline</offsets></p></caption><graphic xlink:href="12970_2018_208_Fig4_HTML" id="MO4"></graphic></fig></p></sec><sec id="Sec21"><title><offsets xml_i="37612" xml_f="37632" txt_i="25271" txt_f="25291">Biochemical analyses</offsets></title><sec id="Sec22"><title><offsets xml_i="37663" xml_f="37678" txt_i="25292" txt_f="25307">Creatine kinase</offsets></title><p id="Par39"><offsets xml_i="37700" xml_f="37768" txt_i="25308" txt_f="25376">Exercise-induced CK was not significantly different between groups (</offsets><italic><offsets xml_i="37776" xml_f="37777" txt_i="25376" txt_f="25377">p</offsets></italic><offsets xml_i="37786" xml_f="37847" txt_i="25377" txt_f="25435"> = 0.9412 with significant time effect (p &lt; 0.0001) (Fig. </offsets><xref rid="Fig5" ref-type="fig"><offsets xml_i="37879" xml_f="37880" txt_i="25435" txt_f="25436">5</offsets></xref><offsets xml_i="37887" xml_f="37895" txt_i="25436" txt_f="25444">, Table </offsets><xref rid="Tab3" ref-type="table"><offsets xml_i="37929" xml_f="37930" txt_i="25444" txt_f="25445">3</offsets></xref><offsets xml_i="37937" xml_f="37939" txt_i="25445" txt_f="25447">).</offsets><fig id="Fig5"><label><offsets xml_i="37961" xml_f="37967" txt_i="25447" txt_f="25453">Fig. 5</offsets></label><caption><p><offsets xml_i="37987" xml_f="38064" txt_i="25453" txt_f="25530">Creatine kinase. Delta Creatine kinase [U/L] (Mean ± 95% CI; product effect: </offsets><italic><offsets xml_i="38072" xml_f="38073" txt_i="25530" txt_f="25531">p</offsets></italic><offsets xml_i="38082" xml_f="38135" txt_i="25531" txt_f="25584"> = 0.9412) * indicating significance against baseline</offsets></p></caption><graphic xlink:href="12970_2018_208_Fig5_HTML" id="MO5"></graphic></fig></p><p id="Par40"><offsets xml_i="38239" xml_f="38468" txt_i="25586" txt_f="25815">In the lemon verbena group, CK was significantly increased above baseline at 24 h but not 3- or 48-h post-exercise. In contrast, the placebo group showed significant elevations of CK at all three time points relative to baseline.</offsets></p></sec><sec id="Sec23"><title><offsets xml_i="38501" xml_f="38523" txt_i="25817" txt_f="25839">Glutathione peroxidase</offsets></title><p id="Par42"><offsets xml_i="38545" xml_f="38640" txt_i="25840" txt_f="25935">The GPxP activity within lemon verbena group was increased by trend compared to placebo group (</offsets><italic><offsets xml_i="38648" xml_f="38649" txt_i="25935" txt_f="25936">p</offsets></italic><offsets xml_i="38658" xml_f="38702" txt_i="25936" txt_f="25980"> = 0.0681), with time effect also by trend (</offsets><italic><offsets xml_i="38710" xml_f="38711" txt_i="25980" txt_f="25981">p</offsets></italic><offsets xml_i="38720" xml_f="38738" txt_i="25981" txt_f="25999"> = 0.0624), (Fig. </offsets><xref rid="Fig6" ref-type="fig"><offsets xml_i="38770" xml_f="38771" txt_i="25999" txt_f="26000">6</offsets></xref><offsets xml_i="38778" xml_f="38786" txt_i="26000" txt_f="26008">, Table </offsets><xref rid="Tab3" ref-type="table"><offsets xml_i="38820" xml_f="38821" txt_i="26008" txt_f="26009">3</offsets></xref><offsets xml_i="38828" xml_f="38830" txt_i="26009" txt_f="26011">).</offsets><fig id="Fig6"><label><offsets xml_i="38852" xml_f="38858" txt_i="26011" txt_f="26017">Fig. 6</offsets></label><caption><p><offsets xml_i="38878" xml_f="38969" txt_i="26017" txt_f="26108">Glutathione peroxidase. Delta Glutathione peroxidase [U/L] (Mean ± 95% CI; product effect: </offsets><italic><offsets xml_i="38977" xml_f="38978" txt_i="26108" txt_f="26109">p</offsets></italic><offsets xml_i="38987" xml_f="39040" txt_i="26109" txt_f="26162"> = 0.0681) * indicating significance against baseline</offsets></p></caption><graphic xlink:href="12970_2018_208_Fig6_HTML" id="MO6"></graphic></fig></p></sec><sec id="Sec24"><title><offsets xml_i="39159" xml_f="39172" txt_i="26165" txt_f="26178">Interleukin 6</offsets></title><p id="Par43"><offsets xml_i="39194" xml_f="39379" txt_i="26179" txt_f="26364">Only distinct increase of IL-6 could be observed after exercise, without significant differences but high inter-individual variability. Differences between groups were not significant (</offsets><italic><offsets xml_i="39387" xml_f="39388" txt_i="26364" txt_f="26365">p</offsets></italic><offsets xml_i="39397" xml_f="39408" txt_i="26365" txt_f="26376"> = 0.5824).</offsets></p></sec></sec><sec id="Sec25"><title><offsets xml_i="39447" xml_f="39470" txt_i="26379" txt_f="26402">Safety and tolerability</offsets></title><p id="Par44"><offsets xml_i="39492" xml_f="39695" txt_i="26403" txt_f="26606">Blood chemistry, vital signs, adverse events, and concomitant medication did not indicate any safety concerns over 15 days. There was no statistical difference between the two groups for adverse events (</offsets><italic><offsets xml_i="39703" xml_f="39704" txt_i="26606" txt_f="26607">p</offsets></italic><offsets xml_i="39713" xml_f="39966" txt_i="26607" txt_f="26860"> = 0.231). The most frequent adverse events were headache (lemon verbena: 5%, placebo: 18%) and common cold (lemon verbena 23%, placebo: 23%). None of the adverse events were serious or related to the study products. The intervention was well tolerated.</offsets></p></sec></sec><sec id="Sec26"><title><offsets xml_i="40005" xml_f="40015" txt_i="26863" txt_f="26873">Discussion</offsets></title><p id="Par45"><offsets xml_i="40037" xml_f="40444" txt_i="26874" txt_f="27281">The aim of this study was to investigate the effects of supplementing with 400 mg of lemon verbena extract (Recoverben®) on muscle strength and recovery in healthy, moderately active adults. We found that consumption of lemon verbena significantly attenuated loss of muscle strength compared to placebo. Muscle strength loss is considered a reliable and valid functional marker for assessing muscle damage [</offsets><xref ref-type="bibr" rid="CR1"><offsets xml_i="40476" xml_f="40477" txt_i="27281" txt_f="27282">1</offsets></xref><offsets xml_i="40484" xml_f="40592" txt_i="27282" txt_f="27390">]. Therefore, our preliminary findings suggest that lemon verbena may reduce exercise-induced muscle damage.</offsets></p><p id="Par46"><offsets xml_i="40610" xml_f="40891" txt_i="27391" txt_f="27672">Muscle strength was reduced by 21% in placebo group, which is within the expected range of 20–50% and recovery was not completed until two days post exercise. It is generally accepted that two to seven days are necessary for full recovery following exercise induced muscle damage [</offsets><xref ref-type="bibr" rid="CR1"><offsets xml_i="40923" xml_f="40924" txt_i="27672" txt_f="27673">1</offsets></xref><offsets xml_i="40931" xml_f="40992" txt_i="27673" txt_f="27734">]. Compared to placebo, lemon verbena extract significantly (</offsets><italic><offsets xml_i="41000" xml_f="41001" txt_i="27734" txt_f="27735">p</offsets></italic><offsets xml_i="41010" xml_f="41151" txt_i="27735" txt_f="27876"> = 0.0311) buffered strength loss after exercise. MVC in the lemon verbena group was reduced by 11%, which is defined as mild muscle damage [</offsets><xref ref-type="bibr" rid="CR1"><offsets xml_i="41183" xml_f="41184" txt_i="27876" txt_f="27877">1</offsets></xref><offsets xml_i="41191" xml_f="41372" txt_i="27877" txt_f="28058">]. Furthermore, complete recovery was reached after 48 h. Based on these findings, lemon verbena appears to not only speed recovery, but also reduce fatigue directly after exercise.</offsets></p><p id="Par47"><offsets xml_i="41390" xml_f="41961" txt_i="28059" txt_f="28630">These results were reflected by findings for perceived muscle soreness. Movement induced pain, which estimated actual perceived pain showed discrimination between study groups with slight superiority of lemon verbena extract by trend. The less pronounced muscle damage, seen by significantly less reduction of MVC, seems to be reflected by less perceived pain under lemon verbena extract if compared to placebo. Maximum of muscle soreness was reported 48 h after exercise, fitting to the general knowledge that muscle soreness peaks 24 h or 48 h after damaging exercise [</offsets><xref ref-type="bibr" rid="CR1"><offsets xml_i="41993" xml_f="41994" txt_i="28630" txt_f="28631">1</offsets></xref><offsets xml_i="42001" xml_f="42343" txt_i="28631" txt_f="28973">]. The extent of muscle soreness was medium for both groups, supporting that the exercise protocol caused mild to moderate muscle damage. After 96 h, subjects were, on average, not completely painless, even if muscle strength at that time was already recovered in this group. However, the same phenomenon has already been observed by others [</offsets><xref ref-type="bibr" rid="CR9"><offsets xml_i="42375" xml_f="42376" txt_i="28973" txt_f="28974">9</offsets></xref><offsets xml_i="42383" xml_f="42385" txt_i="28974" txt_f="28976">, </offsets><xref ref-type="bibr" rid="CR33"><offsets xml_i="42418" xml_f="42420" txt_i="28976" txt_f="28978">33</offsets></xref><offsets xml_i="42427" xml_f="42429" txt_i="28978" txt_f="28980">].</offsets></p><p id="Par48"><offsets xml_i="42447" xml_f="42577" txt_i="28981" txt_f="29111">Increasing concentration of CK in the blood is an indication of muscle damage, being frequently used in sports nutrition studies [</offsets><xref ref-type="bibr" rid="CR9"><offsets xml_i="42609" xml_f="42610" txt_i="29111" txt_f="29112">9</offsets></xref><offsets xml_i="42617" xml_f="42619" txt_i="29112" txt_f="29114">, </offsets><xref ref-type="bibr" rid="CR35"><offsets xml_i="42652" xml_f="42654" txt_i="29114" txt_f="29116">35</offsets></xref><offsets xml_i="42661" xml_f="42782" txt_i="29116" txt_f="29237">]. The time course of CK increase peaked at 24 h after exercise, which is comparable to findings reported in literature [</offsets><xref ref-type="bibr" rid="CR9"><offsets xml_i="42814" xml_f="42815" txt_i="29237" txt_f="29238">9</offsets></xref><offsets xml_i="42822" xml_f="42824" txt_i="29238" txt_f="29240">, </offsets><xref ref-type="bibr" rid="CR35"><offsets xml_i="42857" xml_f="42859" txt_i="29240" txt_f="29242">35</offsets></xref><offsets xml_i="42866" xml_f="43072" txt_i="29242" txt_f="29448">]. Exercise-induced increases in CK are known to exhibit high interindividual variability, with some people showing large increases (responders) and others showing only moderate increases (non-responders) [</offsets><xref ref-type="bibr" rid="CR1"><offsets xml_i="43104" xml_f="43105" txt_i="29448" txt_f="29449">1</offsets></xref><offsets xml_i="43112" xml_f="43375" txt_i="29449" txt_f="29712">]. In our study, high levels of interindividual variation in CK concentrations were present, which could explain why we failed to observe a significant between-group difference despite other markers of muscle damage, such as MVC, favoring the lemon verbena group.</offsets></p><p id="Par49"><offsets xml_i="43393" xml_f="43558" txt_i="29713" txt_f="29878">Many research studies have shown that supplementation with dietary polyphenols has the potential to positively influence symptoms of exercise-induced muscle damage [</offsets><xref ref-type="bibr" rid="CR2"><offsets xml_i="43590" xml_f="43591" txt_i="29878" txt_f="29879">2</offsets></xref><offsets xml_i="43598" xml_f="43600" txt_i="29879" txt_f="29881">, </offsets><xref ref-type="bibr" rid="CR5"><offsets xml_i="43632" xml_f="43633" txt_i="29881" txt_f="29882">5</offsets></xref><offsets xml_i="43640" xml_f="43642" txt_i="29882" txt_f="29884">, </offsets><xref ref-type="bibr" rid="CR8"><offsets xml_i="43674" xml_f="43675" txt_i="29884" txt_f="29885">8</offsets></xref><offsets xml_i="43682" xml_f="43683" txt_i="29885" txt_f="29886">–</offsets><xref ref-type="bibr" rid="CR10"><offsets xml_i="43716" xml_f="43718" txt_i="29886" txt_f="29888">10</offsets></xref><offsets xml_i="43725" xml_f="43727" txt_i="29888" txt_f="29890">, </offsets><xref ref-type="bibr" rid="CR41"><offsets xml_i="43760" xml_f="43762" txt_i="29890" txt_f="29892">41</offsets></xref><offsets xml_i="43769" xml_f="43771" txt_i="29892" txt_f="29894">, </offsets><xref ref-type="bibr" rid="CR19"><offsets xml_i="43804" xml_f="43806" txt_i="29894" txt_f="29896">19</offsets></xref><offsets xml_i="43813" xml_f="43938" txt_i="29896" txt_f="30021">]. However, underlying processes are still unclear and it is not sure if antioxidative effects are the primarily mechanisms [</offsets><xref ref-type="bibr" rid="CR41"><offsets xml_i="43971" xml_f="43973" txt_i="30021" txt_f="30023">41</offsets></xref><offsets xml_i="43980" xml_f="44067" txt_i="30023" txt_f="30110">]. Furthermore, the benefit of reducing oxidative stress has been discussed diversely [</offsets><xref ref-type="bibr" rid="CR41"><offsets xml_i="44100" xml_f="44102" txt_i="30110" txt_f="30112">41</offsets></xref><offsets xml_i="44109" xml_f="44111" txt_i="30112" txt_f="30114">, </offsets><xref ref-type="bibr" rid="CR42"><offsets xml_i="44144" xml_f="44146" txt_i="30114" txt_f="30116">42</offsets></xref><offsets xml_i="44153" xml_f="44256" txt_i="30116" txt_f="30219">]. Increased of oxidative stress can lead to progressive cell damage and decline in physical function [</offsets><xref ref-type="bibr" rid="CR42"><offsets xml_i="44289" xml_f="44291" txt_i="30219" txt_f="30221">42</offsets></xref><offsets xml_i="44298" xml_f="44300" txt_i="30221" txt_f="30223">, </offsets><xref ref-type="bibr" rid="CR43"><offsets xml_i="44333" xml_f="44335" txt_i="30223" txt_f="30225">43</offsets></xref><offsets xml_i="44342" xml_f="44431" txt_i="30225" txt_f="30314">]. However, ROS act as biological stimuli in cellular processes of adaption to training [</offsets><xref ref-type="bibr" rid="CR41"><offsets xml_i="44464" xml_f="44466" txt_i="30314" txt_f="30316">41</offsets></xref><offsets xml_i="44473" xml_f="44475" txt_i="30316" txt_f="30318">, </offsets><xref ref-type="bibr" rid="CR42"><offsets xml_i="44508" xml_f="44510" txt_i="30318" txt_f="30320">42</offsets></xref><offsets xml_i="44517" xml_f="44605" txt_i="30320" txt_f="30408">] and cells can adapt to repetitive increases of ROS by improving antioxidant capacity [</offsets><xref ref-type="bibr" rid="CR44"><offsets xml_i="44638" xml_f="44640" txt_i="30408" txt_f="30410">44</offsets></xref><offsets xml_i="44647" xml_f="44649" txt_i="30410" txt_f="30412">, </offsets><xref ref-type="bibr" rid="CR45"><offsets xml_i="44682" xml_f="44684" txt_i="30412" txt_f="30414">45</offsets></xref><offsets xml_i="44691" xml_f="45482" txt_i="30414" txt_f="31205">]. During the current study, glutathione peroxidase in plasma was selected as a parameter to supply information about antioxidative capacity. Our results indicate an activation of the antioxidative defense under lemon verbena extract by up-regulating GPxP shortly after exercise. In contrast to this, baseline GPxP was not increased by supplementation with lemon verbena extract. Therefore, it appears, that supplementation with lemon verbena extract strengthens the antioxidative defense system and enables effective counteraction of oxidative stress, but only if needed. Both groups experienced significant exercise-induced increases in IL-6 without significant difference between one another. Some evidence suggests that changes in IL-6 depend in part on exercise intensity and duration [</offsets><xref ref-type="bibr" rid="CR1"><offsets xml_i="45514" xml_f="45515" txt_i="31205" txt_f="31206">1</offsets></xref><offsets xml_i="45522" xml_f="45524" txt_i="31206" txt_f="31208">, </offsets><xref ref-type="bibr" rid="CR46"><offsets xml_i="45557" xml_f="45559" txt_i="31208" txt_f="31210">46</offsets></xref><offsets xml_i="45566" xml_f="45568" txt_i="31210" txt_f="31212">, </offsets><xref ref-type="bibr" rid="CR40"><offsets xml_i="45601" xml_f="45603" txt_i="31212" txt_f="31214">40</offsets></xref><offsets xml_i="45610" xml_f="45983" txt_i="31214" txt_f="31587">]. It is possible that the exhaustive exercise protocol used in our study was not intense and/or long enough to elicit meaningful changes in IL-6 that could have been effected by lemon verbena supplementation. Similar results were found in other human studies investigating natural ingredients for effects of muscle strength and muscle damage, such as ashwagandha extract [</offsets><xref ref-type="bibr" rid="CR47"><offsets xml_i="46016" xml_f="46018" txt_i="31587" txt_f="31589">47</offsets></xref><offsets xml_i="46025" xml_f="46038" txt_i="31589" txt_f="31602">], curcumin [</offsets><xref ref-type="bibr" rid="CR48"><offsets xml_i="46071" xml_f="46073" txt_i="31602" txt_f="31604">48</offsets></xref><offsets xml_i="46080" xml_f="46104" txt_i="31604" txt_f="31628">], pomegranate extract [</offsets><xref ref-type="bibr" rid="CR10"><offsets xml_i="46137" xml_f="46139" txt_i="31628" txt_f="31630">10</offsets></xref><offsets xml_i="46146" xml_f="46164" txt_i="31630" txt_f="31648">], and blueberry [</offsets><xref ref-type="bibr" rid="CR2"><offsets xml_i="46196" xml_f="46197" txt_i="31648" txt_f="31649">2</offsets></xref><offsets xml_i="46204" xml_f="46392" txt_i="31649" txt_f="31837">]. These natural ingredients are high in polyphenols, a trait shared by lemon verbena. It has been proposed, that polyphenols could be useful to prevent muscle damage or improve recovery [</offsets><xref ref-type="bibr" rid="CR4"><offsets xml_i="46424" xml_f="46425" txt_i="31837" txt_f="31838">4</offsets></xref><offsets xml_i="46432" xml_f="46649" txt_i="31838" txt_f="32055">]. The major biological functions of polyphenols are as antioxidants and anti-inflammatory agents. Enhanced production of vasodilation factors and the inhibition of synthesis of vasoconstrictors have also been shown [</offsets><xref ref-type="bibr" rid="CR49"><offsets xml_i="46682" xml_f="46684" txt_i="32055" txt_f="32057">49</offsets></xref><offsets xml_i="46691" xml_f="46931" txt_i="32057" txt_f="32297">]. These could be additionally beneficial by improving tissue oxygen supply and removal of metabolic waste products. The proprietary lemon verbena extract (Recoverben®) investigated in the current study has shown anti-inflammatory effects [</offsets><xref ref-type="bibr" rid="CR26"><offsets xml_i="46964" xml_f="46966" txt_i="32297" txt_f="32299">26</offsets></xref><offsets xml_i="46973" xml_f="47300" txt_i="32299" txt_f="32626">] and is characterized by a high polyphenol content and high ORAC level. Therefore, the observed reduction in muscle strength loss and indicated accelerated recovery in the present study might be explained by lemon verbenas’ constituents and their ability to prevent or reduce inflammatory processes or reduce oxidative stress.</offsets></p></sec><sec id="Sec27"><title><offsets xml_i="47333" xml_f="47343" txt_i="32628" txt_f="32638">Conclusion</offsets></title><p id="Par50"><offsets xml_i="47365" xml_f="47845" txt_i="32639" txt_f="33119">In summary, our study showed that ingestion of a 400 mg/day proprietary lemon verbena extract (Recoverben®) resulted in significantly less muscle strength loss in healthy, moderately active adults. Influences by trend on muscle soreness and antioxidative capacity emphasizes the potential of the product accelerating recovery after exhaustive exercise. Larger studies could provide statistical evidence also for the parameter, which only showed improvements by trend in the study.</offsets></p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>CK</term><def><p id="Par1">Creatine kinase</p></def></def-item><def-item><term>DOMS</term><def><p id="Par2">Delayed onset of muscle soreness</p></def></def-item><def-item><term>eiMD</term><def><p id="Par3">Exercise-induced muscle damage</p></def></def-item><def-item><term>GPx</term><def><p id="Par4">Glutathione peroxidase</p></def></def-item><def-item><term>GPxP</term><def><p id="Par5">Glutathione peroxidase in Plasma</p></def></def-item><def-item><term>IL-6</term><def><p id="Par6">Interleukin 6</p></def></def-item><def-item><term>MVC</term><def><p id="Par7">Maximal voluntary contraction</p></def></def-item><def-item><term>ROS</term><def><p id="Par8">Reactive oxygen species</p></def></def-item><def-item><term>RPE</term><def><p id="Par9">Rating of perceived exertion</p></def></def-item><def-item><term>VAS</term><def><p id="Par10">Visual analogue scale</p></def></def-item></def-list></glossary><ack><title>Acknowledgements</title><p>The authors would like to thank all subjects taking part in the trial.</p><sec id="FPar3"><title>Funding</title><p id="Par52">Despite sponsoring by Vital Solutions GmbH, no further funding was received.</p></sec><sec id="FPar4"><title>Availability of data and materials</title><p id="Par53">Please contact corresponding author for additional data.</p></sec></ack><notes notes-type="author-contribution"><title>Authors’ contributions</title><p>The study was designed by CAR, ES and CS (BioTeSys GmbH) after approach from SBW, IN (Vital Solutions GmbH). CAR, ES and CS undertook management of the study, including study execution, overseeing data collection, management, quality assurance and analyses. MW (Ulm University of Applied Sciences) performed the statistical analysis. All authors contributed to the study design and data interpretation. SBW and CAR wrote the first draft of this paper and all authors were responsible for subsequent critical revision of the manuscript. SBW is the corresponding author for this paper. All authors read and approved the final manuscript.</p></notes><notes notes-type="COI-statement"><sec id="FPar5"><title>Authors’ information</title><p id="Par54">SBW, Pharmacist, PhD in Pharmaceutical Chemistry, over 20 years experience in the natural product industry for health and nutrition. Managing Director and head of R&amp;D at Vital Solutions GmbH, Hausingerstrasse 6, Langenfeld, 40,764, Germany.</p><p id="Par55">IN, Dipl. Chemical engineer, Master in Natural product chemistry, Scientific Manager at Vital Solutions GmbH, Hausingerstrasse 6, Langenfeld, 40,764, Germany.</p><p id="Par56">CS (Dipl. Nutrition science) and CAR (PhD Sports science and examin. Biol.), both clinical research scientists at BioTeSys GmbH, a company with over 15 years experience in the field of nutrition research and clinical nutrition studies. ES, student of molecular nutritional science at University of Hohenheim and trainee at BioTeSys GmbH, Schelztorstrasse 54–56, Esslingen, D-73728, Germany. MW, professor for mathematics and statistics at the. Ulm University of Applied Sciences, Albert-Einstein-Allee 55, 89,081 Ulm, Germany.</p></sec><sec id="FPar2"><title>Ethics approval and consent to participate</title><p id="Par51">Ethical approval was obtained from the ethical committee of the “Landesärztekammer Baden-Württemberg” without concerns (F-2016-080 September 13th, 2016) prior to study start and all subjects signed the IRB-approved informed consent prior to any procedures.</p></sec><sec id="FPar6"><title>Consent for publication</title><p id="Par57">Not applicable.</p></sec><sec id="FPar7"><title>Competing interests</title><p id="Par58">The study was sponsored by Vital Solutions GmbH. The sponsors contributed to discussion about study design and selection of outcome measures prior to study start. During study realization and data analysis all data were completely blinded and study realization, data analysis and report generating were undertaken independently by BioTeSys GmbH and Ulm University of Applied Sciences. Vital Solutions own the proprietary ingredient used in the study. The authors from BioTeSys GmbH and Ulm University of Applied Sciences declare that there is no conflict or interest regarding the publication of this paper.</p></sec><sec id="FPar8"><title>Publisher’s Note</title><p id="Par59">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">Paulsen G, Mikkelsen UR, Raastad T, Peake JM. Leucocytes, cytokines and satellite cells: what role do they play in muscle damage and regeneration following eccentric exercise? Exerc Immunol Rev. 2012;18:42-97.</mixed-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLeay</surname><given-names>Y</given-names></name><name><surname>Barnes</surname><given-names>MJ</given-names></name><name><surname>Mundel</surname><given-names>T</given-names></name><name><surname>Hurst</surname><given-names>SM</given-names></name><name><surname>Hurst</surname><given-names>RD</given-names></name><name><surname>Stannard</surname><given-names>SR</given-names></name></person-group><article-title>Effect of New Zealand blueberry consumption on recovery from eccentric exercise-induced muscle damage</article-title><source>J Int Soc Sports Nutr.</source><year>2012</year><volume>9</volume><fpage>19</fpage><pub-id pub-id-type="doi">10.1186/1550-2783-9-19</pub-id><pub-id pub-id-type="pmid">22564864</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meamarbashi</surname><given-names>A</given-names></name></person-group><article-title>Herbs and natural supplements in the prevention and treatment of delayed-onset muscle soreness</article-title><source>Avicenna J Phytomed</source><year>2017</year><volume>7</volume><fpage>16</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">28265543</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>JA</given-names></name></person-group><article-title>Review of nutritional intervention on delayed onset muscle soreness. Part I</article-title><source>J Exerc Rehabil</source><year>2014</year><volume>10</volume><fpage>349</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.12965/jer.140179</pub-id><pub-id pub-id-type="pmid">25610818</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McFarlin</surname><given-names>BK</given-names></name><name><surname>Venable</surname><given-names>AS</given-names></name><name><surname>Henning</surname><given-names>AL</given-names></name><name><surname>Sampson</surname><given-names>JN</given-names></name><name><surname>Pennel</surname><given-names>K</given-names></name><name><surname>Vingren</surname><given-names>JL</given-names></name><etal></etal></person-group><article-title>Reduced inflammatory and muscle damage biomarkers following oral supplementation with bioavailable curcumin</article-title><source>BBA Clin</source><year>2016</year><volume>5</volume><fpage>72</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1016/j.bbacli.2016.02.003</pub-id><pub-id pub-id-type="pmid">27051592</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tartibian</surname><given-names>B</given-names></name><name><surname>Maleki</surname><given-names>BH</given-names></name><name><surname>Abbasi</surname><given-names>A</given-names></name></person-group><article-title>Omega-3 fatty acids supplementation attenuates inflammatory markers after eccentric exercise in untrained men</article-title><source>Clin J Sport Med</source><year>2011</year><volume>21</volume><fpage>131</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1097/JSM.0b013e31820f8c2f</pub-id><pub-id pub-id-type="pmid">21358504</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>EJ</given-names></name><name><surname>Radonic</surname><given-names>PW</given-names></name><name><surname>Wolever</surname><given-names>TM</given-names></name><name><surname>Wells</surname><given-names>GD</given-names></name></person-group><article-title>21 days of mammalian omega-3 fatty acid supplementation improves aspects of neuromuscular function and performance in male athletes compared to olive oil placebo</article-title><source>J Int Soc Sports Nutr</source><year>2015</year><volume>12</volume><fpage>28</fpage><pub-id pub-id-type="doi">10.1186/s12970-015-0089-4</pub-id><pub-id pub-id-type="pmid">26085822</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cases</surname><given-names>J</given-names></name><name><surname>Romain</surname><given-names>C</given-names></name><name><surname>Marin-Pagan</surname><given-names>C</given-names></name><name><surname>Chung</surname><given-names>LH</given-names></name><name><surname>Rubio-Perez</surname><given-names>JM</given-names></name><name><surname>Laurent</surname><given-names>C</given-names></name><etal></etal></person-group><article-title>Supplementation with a polyphenol-rich extract, PerfLoad(R), improves physical performance during high-intensity exercise: a randomized, double blind, crossover trial</article-title><source>Nutrients</source><year>2017</year><volume>9</volume><fpage>E421</fpage><pub-id pub-id-type="doi">10.3390/nu9040421</pub-id><pub-id pub-id-type="pmid">28441760</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Connolly</surname><given-names>DA</given-names></name><name><surname>McHugh</surname><given-names>MP</given-names></name><name><surname>Padilla-Zakour</surname><given-names>OI</given-names></name><name><surname>Carlson</surname><given-names>L</given-names></name><name><surname>Sayers</surname><given-names>SP</given-names></name></person-group><article-title>Efficacy of a tart cherry juice blend in preventing the symptoms of muscle damage</article-title><source>Br J Sports Med</source><year>2006</year><volume>40</volume><fpage>679</fpage><lpage>683</lpage><pub-id pub-id-type="doi">10.1136/bjsm.2005.025429</pub-id><pub-id pub-id-type="pmid">16790484</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trombold</surname><given-names>JR</given-names></name><name><surname>Barnes</surname><given-names>JN</given-names></name><name><surname>Critchley</surname><given-names>L</given-names></name><name><surname>Coyle</surname><given-names>EF</given-names></name></person-group><article-title>Ellagitannin consumption improves strength recovery 2-3 d after eccentric exercise</article-title><source>Med Sci Sports Exerc</source><year>2010</year><volume>42</volume><fpage>493</fpage><lpage>498</lpage><pub-id pub-id-type="doi">10.1249/MSS.0b013e3181b64edd</pub-id><pub-id pub-id-type="pmid">19952825</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lenoir</surname><given-names>L</given-names></name><name><surname>Rossary</surname><given-names>A</given-names></name><name><surname>Joubert-Zakeyh</surname><given-names>J</given-names></name><name><surname>Vergnaud-Gauduchon</surname><given-names>J</given-names></name><name><surname>Farges</surname><given-names>MC</given-names></name><name><surname>Fraisse</surname><given-names>D</given-names></name><etal></etal></person-group><article-title>Lemon verbena infusion consumption attenuates oxidative stress in dextran sulfate sodium-induced colitis in the rat</article-title><source>Dig Dis Sci</source><year>2011</year><volume>56</volume><fpage>3534</fpage><lpage>3545</lpage><pub-id pub-id-type="doi">10.1007/s10620-011-1784-x</pub-id><pub-id pub-id-type="pmid">21688009</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bilia</surname><given-names>AR</given-names></name><name><surname>Giomi</surname><given-names>M</given-names></name><name><surname>Innocenti</surname><given-names>M</given-names></name><name><surname>Gallori</surname><given-names>S</given-names></name><name><surname>Vincieri</surname><given-names>FF</given-names></name></person-group><article-title>HPLC-DAD-ESI-MS analysis of the constituents of aqueous preparations of verbena and lemon verbena and evaluation of the antioxidant activity</article-title><source>J Pharm Biomed Anal</source><year>2008</year><volume>46</volume><fpage>463</fpage><lpage>470</lpage><pub-id pub-id-type="doi">10.1016/j.jpba.2007.11.007</pub-id><pub-id pub-id-type="pmid">18155378</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quirantes-Pine</surname><given-names>R</given-names></name><name><surname>Funes</surname><given-names>L</given-names></name><name><surname>Micol</surname><given-names>V</given-names></name><name><surname>Segura-Carretero</surname><given-names>A</given-names></name><name><surname>Fernandez-Gutierrez</surname><given-names>A</given-names></name></person-group><article-title>High-performance liquid chromatography with diode array detection coupled to electrospray time-of-flight and ion-trap tandem mass spectrometry to identify phenolic compounds from a lemon verbena extract</article-title><source>J Chromatogr A</source><year>2009</year><volume>1216</volume><fpage>5391</fpage><lpage>5397</lpage><pub-id pub-id-type="doi">10.1016/j.chroma.2009.05.038</pub-id><pub-id pub-id-type="pmid">19500792</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Felgines</surname><given-names>C</given-names></name><name><surname>Fraisse</surname><given-names>D</given-names></name><name><surname>Besson</surname><given-names>C</given-names></name><name><surname>Vasson</surname><given-names>MP</given-names></name><name><surname>Texier</surname><given-names>O</given-names></name></person-group><article-title>Bioavailability of lemon verbena (Aloysia Triphylla) polyphenols in rats: impact of colonic inflammation</article-title><source>Br J Nutr</source><year>2014</year><volume>111</volume><fpage>1773</fpage><lpage>1781</lpage><pub-id pub-id-type="doi">10.1017/S0007114514000026</pub-id><pub-id pub-id-type="pmid">24513110</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Portmann</surname><given-names>E</given-names></name><name><surname>Nigro</surname><given-names>MM</given-names></name><name><surname>Reides</surname><given-names>CG</given-names></name><name><surname></surname><given-names>S</given-names></name><name><surname>Ricco</surname><given-names>RA</given-names></name><name><surname>Wagner</surname><given-names>ML</given-names></name><etal></etal></person-group><article-title>Aqueous extracts of Lippia Turbinata and Aloysia Citriodora (Verbenaceae): assessment of antioxidant capacity and DNA damage</article-title><source>Int J Toxicol</source><year>2012</year><volume>31</volume><fpage>192</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1177/1091581812436726</pub-id><pub-id pub-id-type="pmid">22427199</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abderrahim</surname><given-names>F</given-names></name><name><surname>Estrella</surname><given-names>S</given-names></name><name><surname>Susin</surname><given-names>C</given-names></name><name><surname>Arribas</surname><given-names>SM</given-names></name><name><surname>Gonzalez</surname><given-names>MC</given-names></name><name><surname>Condezo-Hoyos</surname><given-names>L</given-names></name></person-group><article-title>The antioxidant activity and thermal stability of lemon verbena (Aloysia Triphylla) infusion</article-title><source>J Med Food</source><year>2011</year><volume>14</volume><fpage>517</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1089/jmf.2010.0102</pub-id><pub-id pub-id-type="pmid">21434775</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ponce-Monter</surname><given-names>H</given-names></name><name><surname>Fernandez-Martinez</surname><given-names>E</given-names></name><name><surname>Ortiz</surname><given-names>MI</given-names></name><name><surname>Ramirez-Montiel</surname><given-names>ML</given-names></name><name><surname>Cruz-Elizalde</surname><given-names>D</given-names></name><name><surname>Perez-Hernandez</surname><given-names>N</given-names></name><etal></etal></person-group><article-title>Spasmolytic and anti-inflammatory effects of Aloysia Triphylla and citral, in vitro and in vivo studies</article-title><source>J Smooth Muscle Res</source><year>2010</year><volume>46</volume><fpage>309</fpage><lpage>319</lpage><pub-id pub-id-type="doi">10.1540/jsmr.46.309</pub-id><pub-id pub-id-type="pmid">21441718</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="other">Choupani M, Arabshahi S, Alami M. Antioxidant properties of various solvent extracts of lemon verbena (Lippia Citriodora) leaves. Int J Adv Biol Biomed Res. 2014;2</mixed-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Funes</surname><given-names>L</given-names></name><name><surname>Carrera-Quintanar</surname><given-names>L</given-names></name><name><surname>Cerdan-Calero</surname><given-names>M</given-names></name><name><surname>Ferrer</surname><given-names>MD</given-names></name><name><surname>Drobnic</surname><given-names>F</given-names></name><name><surname>Pons</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>Effect of lemon verbena supplementation on muscular damage markers, proinflammatory cytokines release and neutrophils' oxidative stress in chronic exercise</article-title><source>Eur J Appl Physiol</source><year>2011</year><volume>111</volume><fpage>695</fpage><lpage>705</lpage><pub-id pub-id-type="doi">10.1007/s00421-010-1684-3</pub-id><pub-id pub-id-type="pmid">20967458</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mauriz</surname><given-names>E</given-names></name><name><surname>Vallejo</surname><given-names>D</given-names></name><name><surname>Tunon</surname><given-names>MJ</given-names></name><name><surname>Rodriguez-Lopez</surname><given-names>JM</given-names></name><name><surname>Rodriguez-Perez</surname><given-names>R</given-names></name><name><surname>Sanz-Gomez</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>Effects of dietary supplementation with lemon verbena extracts on serum inflammatory markers of multiple sclerosis patients</article-title><source>Nutr Hosp</source><year>2014</year><volume>31</volume><fpage>764</fpage><lpage>771</lpage><pub-id pub-id-type="pmid">25617561</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrera-Quintanar</surname><given-names>L</given-names></name><name><surname>Funes</surname><given-names>L</given-names></name><name><surname>Vicente-Salar</surname><given-names>N</given-names></name><name><surname>Blasco-Lafarga</surname><given-names>C</given-names></name><name><surname>Pons</surname><given-names>A</given-names></name><name><surname>Micol</surname><given-names>V</given-names></name><etal></etal></person-group><article-title>Effect of polyphenol supplements on redox status of blood cells: a randomized controlled exercise training trial</article-title><source>Eur J Nutr</source><year>2015</year><volume>54</volume><fpage>1081</fpage><lpage>1093</lpage><pub-id pub-id-type="doi">10.1007/s00394-014-0785-x</pub-id><pub-id pub-id-type="pmid">25326831</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caturla</surname><given-names>N</given-names></name><name><surname>Funes</surname><given-names>L</given-names></name><name><surname>Perez-Fons</surname><given-names>L</given-names></name><name><surname>Micol</surname><given-names>V</given-names></name></person-group><article-title>A randomized, double-blinded, placebo-controlled study of the effect of a combination of lemon verbena extract and fish oil omega-3 fatty acid on joint management</article-title><source>J Altern Complement Med</source><year>2011</year><volume>17</volume><fpage>1051</fpage><lpage>1063</lpage><pub-id pub-id-type="doi">10.1089/acm.2010.0410</pub-id><pub-id pub-id-type="pmid">22087615</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mestre-Alfaro</surname><given-names>A</given-names></name><name><surname>Ferrer</surname><given-names>MD</given-names></name><name><surname>Sureda</surname><given-names>A</given-names></name><name><surname>Tauler</surname><given-names>P</given-names></name><name><surname>Martinez</surname><given-names>E</given-names></name><name><surname>Bibiloni</surname><given-names>MM</given-names></name><etal></etal></person-group><article-title>Phytoestrogens enhance antioxidant enzymes after swimming exercise and modulate sex hormone plasma levels in female swimmers</article-title><source>Eur J Appl Physiol</source><year>2011</year><volume>111</volume><fpage>2281</fpage><lpage>2294</lpage><pub-id pub-id-type="doi">10.1007/s00421-011-1862-y</pub-id><pub-id pub-id-type="pmid">21331628</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrera-Quintanar</surname><given-names>L</given-names></name><name><surname>Funes</surname><given-names>L</given-names></name><name><surname>Viudes</surname><given-names>E</given-names></name><name><surname>Tur</surname><given-names>J</given-names></name><name><surname>Micol</surname><given-names>V</given-names></name><name><surname>Roche</surname><given-names>E</given-names></name><etal></etal></person-group><article-title>Antioxidant effect of lemon verbena extracts in lymphocytes of university students performing aerobic training program</article-title><source>Scand J Med Sci Sports</source><year>2012</year><volume>22</volume><fpage>454</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0838.2010.01244.x</pub-id><pub-id pub-id-type="pmid">21083769</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="other">Justia Trademarks. Recoverben - Trademark Details. 2017. (<ext-link ext-link-type="uri" xlink:href="https://trademarks.justia.com/872/20/recoverben-87220306.html">https://trademarks.justia.com/872/20/recoverben-87220306.html</ext-link>).</mixed-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buchwald-Werner</surname><given-names>S</given-names></name><name><surname>Naka</surname><given-names>I</given-names></name><name><surname>Dressler</surname><given-names>D</given-names></name><name><surname>Reule</surname><given-names>C</given-names></name><name><surname>Schoen</surname><given-names>C</given-names></name></person-group><article-title>Aloysia Citriodora extract targeting sports nutrition. In vitro study on anti-inflammatory effects by cyclooxygenases inhibition</article-title><source>Agro Food ind Hi Tech</source><year>2017</year><volume>28</volume><fpage>42</fpage><lpage>44</lpage></element-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="other">Ahmed M, Qadir MA, Hameed A, Imran M, Muddassar M. Screening of curcumin-derived isoxazole, pyrazoles, and pyrimidines for their anti-inflammatory, antinociceptive, and cyclooxygenase-2 inhibition. Chem Biol Drug Des. 2018;91:338–43.</mixed-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delecroix</surname><given-names>B</given-names></name><name><surname>Abaidia</surname><given-names>AE</given-names></name><name><surname>Leduc</surname><given-names>C</given-names></name><name><surname>Dawson</surname><given-names>B</given-names></name><name><surname>Dupont</surname><given-names>G</given-names></name></person-group><article-title>Curcumin and Piperine supplementation and recovery following exercise induced muscle damage: a randomized controlled trial</article-title><source>J Sports Sci Med</source><year>2017</year><volume>16</volume><fpage>147</fpage><lpage>153</lpage><pub-id pub-id-type="pmid">28344463</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="other">IPAQ Group. International physical activity questionnaire. 2016. Ref Type: Internet Communication.</mixed-citation></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="other">Hug B. Validierung und Weiterentwicklung eines Kurzfragebogens zur Beurteilung des Ernährungsmusters. Institut für Biologische Chemie und Ernährungswissenschaft Prof Dr med H K Biesalski: Diplomarbeit; 2006.</mixed-citation></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="other">Novel Food catalogue <italic>Lippia triphylla</italic>. 2017. <ext-link ext-link-type="uri" xlink:href="http://ec.europa.eu/food/safety/novel_food/catalogue/search/public/index.cfm">http://ec.europa.eu/food/safety/novel_food/catalogue/search/public/index.cfm#</ext-link>#.</mixed-citation></ref><ref id="CR32"><label>32.</label><mixed-citation publication-type="other">Commission regulation (EC) No 1881/2006. 2017. <ext-link ext-link-type="uri" xlink:href="http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:02006R1881-20150731&amp;from=EN">http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:02006R1881-20150731&amp;from=EN</ext-link>. </mixed-citation></ref><ref id="CR33"><label>33.</label><mixed-citation publication-type="other">Howatson G, Hoad M, Goodall S, Tallent J, Bell PG, French DN. Exercise-induced muscle damage is reduced in resistance-trained males by branched chain amino acids: a randomized, double-blind, placebo controlled study. J Int Soc Sports Nutr. 2012;9:20.</mixed-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borg</surname><given-names>GA</given-names></name></person-group><article-title>Psychophysical bases of perceived exertion</article-title><source>Med Sci Sports Exerc</source><year>1982</year><volume>14</volume><fpage>377</fpage><lpage>381</lpage><pub-id pub-id-type="pmid">7154893</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><mixed-citation publication-type="other">Marzin T, Lorkowski G, Reule C, Rau S, Pabst E, Vester JC. Effects of a systemic enzyme therapy in healthy active adults after exhaustive eccentric exercise: a randomised, two-stage, double-blinded, placebo-controlled trial. BMJ Open Sport Exerc Med. 2017;2:e000191.</mixed-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vickers</surname><given-names>AJ</given-names></name></person-group><article-title>Time course of muscle soreness following different types of exercise</article-title><source>BMC Musculoskelet Disord</source><year>2001</year><volume>2</volume><fpage>5</fpage><pub-id pub-id-type="doi">10.1186/1471-2474-2-5</pub-id><pub-id pub-id-type="pmid">11701094</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stolle</surname><given-names>D</given-names></name><name><surname>Rick</surname><given-names>W</given-names></name></person-group><article-title>An improved method for the determination of Creatine kinase activity in serum</article-title><source>J Clin Chem Clin Biochem</source><year>1976</year><volume>14</volume><fpage>239</fpage><lpage>244</lpage><pub-id pub-id-type="pmid">8580</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yavari</surname><given-names>A</given-names></name><name><surname>Javadi</surname><given-names>M</given-names></name><name><surname>Mirmiran</surname><given-names>P</given-names></name><name><surname>Bahadoran</surname><given-names>Z</given-names></name></person-group><article-title>Exercise-induced oxidative stress and dietary antioxidants</article-title><source>Asian J Sports Med</source><year>2015</year><volume>6</volume><fpage>e24898</fpage><pub-id pub-id-type="doi">10.5812/asjsm.24898</pub-id><pub-id pub-id-type="pmid">25883776</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brigelius-Flohe</surname><given-names>R</given-names></name></person-group><article-title>Tissue-specific functions of individual glutathione peroxidases</article-title><source>Free Radic Biol Med</source><year>1999</year><volume>27</volume><fpage>951</fpage><lpage>965</lpage><pub-id pub-id-type="doi">10.1016/S0891-5849(99)00173-2</pub-id><pub-id pub-id-type="pmid">10569628</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><mixed-citation publication-type="other">Reihmane D, Dela F. Interleukin-6: possible biological roles during exercise. Eur J Sport Sci. 2014;14:242-50.</mixed-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira Panza</surname><given-names>VS</given-names></name><name><surname>Diefenthaeler</surname><given-names>F</given-names></name><name><surname>da Silva</surname><given-names>EL</given-names></name></person-group><article-title>Benefits of dietary phytochemical supplementation on eccentric exercise-induced muscle damage: is including antioxidants enough?</article-title><source>Nutrition</source><year>2015</year><volume>31</volume><fpage>1072</fpage><lpage>1082</lpage><pub-id pub-id-type="doi">10.1016/j.nut.2015.02.014</pub-id><pub-id pub-id-type="pmid">26233864</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peternelj</surname><given-names>TT</given-names></name><name><surname>Coombes</surname><given-names>JS</given-names></name></person-group><article-title>Antioxidant supplementation during exercise training: beneficial or detrimental?</article-title><source>Sports Med</source><year>2011</year><volume>41</volume><fpage>1043</fpage><lpage>1069</lpage><pub-id pub-id-type="doi">10.2165/11594400-000000000-00000</pub-id><pub-id pub-id-type="pmid">22060178</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alshammari</surname><given-names>E</given-names></name><name><surname>Shafi</surname><given-names>S</given-names></name><name><surname>Nurmi-Lawton</surname><given-names>J</given-names></name><name><surname>Taylor</surname><given-names>A</given-names></name><name><surname>Lanham-New</surname><given-names>S</given-names></name><name><surname>Ferns</surname><given-names>G</given-names></name></person-group><article-title>Altered antioxidant and trace-element status in adolescent female gymnasts</article-title><source>Int J Sport Nutr Exerc Metab</source><year>2010</year><volume>20</volume><fpage>291</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1123/ijsnem.20.4.291</pub-id><pub-id pub-id-type="pmid">20739717</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niess</surname><given-names>AM</given-names></name><name><surname>Simon</surname><given-names>P</given-names></name></person-group><article-title>Response and adaptation of skeletal muscle to exercise--the role of reactive oxygen species</article-title><source>Front Biosci</source><year>2007</year><volume>12</volume><fpage>4826</fpage><lpage>4838</lpage><pub-id pub-id-type="doi">10.2741/2431</pub-id><pub-id pub-id-type="pmid">17569613</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinbacher</surname><given-names>P</given-names></name><name><surname>Eckl</surname><given-names>P</given-names></name></person-group><article-title>Impact of oxidative stress on exercising skeletal muscle</article-title><source>Biomol Ther</source><year>2015</year><volume>5</volume><fpage>356</fpage><lpage>377</lpage></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peake</surname><given-names>JM</given-names></name><name><surname>Neubauer</surname><given-names>O</given-names></name><name><surname>Della Gatta</surname><given-names>PA</given-names></name><name><surname>Nosaka</surname><given-names>K</given-names></name></person-group><article-title>Muscle damage and inflammation during recovery from exercise</article-title><source>J Appl Physiol (1985)</source><year>2017</year><volume>122</volume><fpage>559</fpage><lpage>570</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.00971.2016</pub-id><pub-id pub-id-type="pmid">28035017</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wankhede</surname><given-names>S</given-names></name><name><surname>Langade</surname><given-names>D</given-names></name><name><surname>Joshi</surname><given-names>K</given-names></name><name><surname>Sinha</surname><given-names>SR</given-names></name><name><surname>Bhattacharyya</surname><given-names>S</given-names></name></person-group><article-title>Examining the effect of Withania Somnifera supplementation on muscle strength and recovery: a randomized controlled trial</article-title><source>J Int Soc Sports Nutr.</source><year>2015</year><volume>12</volume><fpage>43</fpage><pub-id pub-id-type="doi">10.1186/s12970-015-0104-9</pub-id><pub-id pub-id-type="pmid">26609282</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drobnic</surname><given-names>F</given-names></name><name><surname>Riera</surname><given-names>J</given-names></name><name><surname>Appendino</surname><given-names>G</given-names></name><name><surname>Togni</surname><given-names>S</given-names></name><name><surname>Franceschi</surname><given-names>F</given-names></name><name><surname>Valle</surname><given-names>X</given-names></name><etal></etal></person-group><article-title>Reduction of delayed onset muscle soreness by a novel curcumin delivery system (Meriva(R)): a randomised, placebo-controlled trial</article-title><source>J Int Soc Sports Nutr</source><year>2014</year><volume>11</volume><fpage>31</fpage><pub-id pub-id-type="doi">10.1186/1550-2783-11-31</pub-id><pub-id pub-id-type="pmid">24982601</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braakhuis</surname><given-names>AJ</given-names></name><name><surname>Hopkins</surname><given-names>WG</given-names></name></person-group><article-title>Impact of dietary antioxidants on sport performance: a review</article-title><source>Sports Med</source><year>2015</year><volume>45</volume><fpage>939</fpage><lpage>955</lpage><pub-id pub-id-type="doi">10.1007/s40279-015-0323-x</pub-id><pub-id pub-id-type="pmid">25790792</pub-id></element-citation></ref></ref-list></back></article>